rfhg_13426.1

Basic information about the TSS

---

TSS ID: rfhg_13426.1 Species: human Chr: chr1		Start: 154974442 End: 154974452 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2225106,EH38E1386664)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK292143:-31 GeneID: 6464 HGNC/MGI_ID: HGNC:10840 UniProt_ID: Nearer transcript ids and distances:

Gene_name: SHC1 Gene_symbol: SHC1 Gene_synonyms: ShcA p66 Gene_source: HGNC:10840

TATA-Box annotation

---

Distance to TSS:	-71
Nearest PromoterID:	NM_001202859
Entrez ID:	6464
Nearest Unigene:	Hs.433795
Nearest Refseq:	NM_003029
Nearest Ensembl:	ENSG00000160691
Gene Name:	SHC1
Gene Alias:	SHC|SHCA
Gene Type:	protein-coding
CpG%:	0.100000
GC%:	0.545455
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SHC1 p2@SHC1 p3@SHC1 p4@SHC1 p5@SHC1 p6@SHC1 p7@SHC1 p9@SHC1
Sample		p1@SHC1	p2@SHC1	p3@SHC1	p4@SHC1	p5@SHC1	p6@SHC1	p7@SHC1	p9@SHC1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	2.53	9.55	0.00	0.00	0.39	0.97	0.00	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	2.83	8.50	0.00	0.20	0.40	0.81	0.00	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	2.51	13.12	0.00	0.00	0.96	0.19	0.00	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	1.66	10.19	0.00	0.00	0.42	0.21	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	2.92	10.12	0.00	0.00	0.45	0.22	0.22	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	2.52	9.88	0.00	0.00	0.19	0.58	0.00	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1.96	10.68	0.00	0.00	0.65	0.44	0.00	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	2.18	12.11	0.00	0.00	0.97	0.24	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	2.14	10.26	0.00	0.00	0.00	0.43	0.00	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	1.74	10.43	0.00	0.00	0.00	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	1.62	11.32	0.00	0.00	0.40	1.62	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	2.03	8.54	0.00	0.41	0.41	0.81	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	105.42	8.06	8.70	8.54	14.35	1.77	1.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	90.36	9.92	9.47	6.77	11.88	1.50	1.95	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	94.63	10.10	6.59	5.49	15.37	1.98	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	74.69	7.80	7.80	7.29	13.33	0.75	1.51	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	73.38	6.99	7.21	5.46	12.45	0.44	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	63.69	8.01	8.01	9.70	12.23	2.11	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	57.58	4.27	8.53	7.46	14.93	0.53	1.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	116.44	10.08	8.73	8.88	14.89	1.81	0.75	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	97.70	7.35	7.08	8.42	12.83	1.07	1.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	107.03	8.80	6.39	10.36	13.81	1.73	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	80.79	8.53	7.11	8.01	10.73	1.81	1.55	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	98.77	9.71	8.25	7.28	14.07	1.21	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	102.42	9.80	9.80	10.06	13.16	1.03	2.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	88.31	12.66	9.81	2.85	12.34	1.58	1.58	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	68.13	6.04	10.44	9.89	12.64	1.10	1.65	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	131.55	12.26	7.54	8.49	13.44	2.59	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	83.83	9.37	5.17	4.68	12.60	1.29	1.29	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	104.24	11.04	8.69	8.32	11.94	1.09	1.27	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	96.72	6.49	9.21	7.12	14.65	1.26	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	101.40	8.01	8.40	7.82	13.09	0.59	0.59	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	73.23	9.29	4.43	5.70	13.29	0.42	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	53.77	9.73	5.28	4.62	7.09	1.48	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	107.33	9.35	7.85	8.79	15.52	2.43	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	111.91	9.39	6.90	7.86	11.11	1.92	0.77	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	101.99	10.01	7.15	10.01	13.69	1.84	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	91.88	8.06	9.47	6.45	11.08	0.81	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	90.48	10.26	8.91	8.37	14.32	2.43	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	82.82	8.88	6.24	5.76	9.12	1.68	1.20	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	76.69	11.29	4.47	6.35	9.65	0.71	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	62.36	13.18	4.98	3.81	9.66	2.05	0.73	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	102.28	10.54	9.07	8.22	11.18	1.69	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	94.76	10.31	9.62	7.17	11.71	2.45	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	98.58	11.24	6.83	9.03	8.63	2.61	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	85.85	9.07	12.56	4.89	12.10	2.09	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	102.44	9.12	13.43	7.44	11.28	1.20	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	93.29	9.84	12.52	9.84	14.31	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	95.99	9.81	13.64	8.86	10.77	1.91	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	84.72	11.73	12.13	8.90	11.93	2.22	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	87.31	8.20	12.50	7.38	8.81	0.61	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	97.18	12.90	14.90	8.45	15.57	1.33	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	27.98	0.00	0.00	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	89.07	7.81	17.39	7.10	9.23	1.06	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	75.22	10.60	19.55	7.95	9.94	0.99	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	28.52	10.07	4.19	2.52	3.36	2.52	2.52	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	51.44	9.18	7.81	1.84	7.81	2.30	2.76	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	82.32	11.02	32.09	11.99	12.32	1.30	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	93.78	7.71	26.34	14.13	10.92	0.64	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	71.98	12.57	16.35	6.60	6.29	1.26	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	81.08	7.05	29.61	7.05	7.05	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	77.39	5.05	28.60	6.73	9.53	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	70.86	15.92	23.09	11.15	3.18	0.80	1.59	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	75.09	9.17	22.76	6.80	8.49	1.02	1.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	128.99	4.87	42.24	20.15	12.67	0.65	2.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	102.59	6.03	42.24	14.91	8.52	1.42	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	64.66	0.00	0.00	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	15.79	0.00	7.90	0.00	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	101.40	5.36	28.76	8.78	7.31	0.49	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	83.80	7.44	18.35	10.41	7.44	1.98	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	93.35	9.38	24.86	12.20	5.16	0.94	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	114.26	8.28	31.46	7.29	8.61	2.32	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	105.49	5.26	48.26	10.83	8.66	0.93	1.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	102.12	7.34	44.64	8.56	8.26	0.31	1.53	0.00
Adipocyte - breast, donor1	11376-118A8	28.67	11.88	11.09	3.01	3.17	3.48	0.48	0.16
Adipocyte - breast, donor2	11327-117E4	35.61	13.64	13.96	8.18	2.57	3.69	1.28	0.32
Adipocyte - omental, donor1	11473-119C6	27.48	15.90	10.81	7.00	2.29	3.82	0.76	0.25
Adipocyte - omental, donor2	11474-119C7	20.18	6.73	15.70	3.74	1.49	2.99	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	31.82	9.04	8.04	9.71	3.01	0.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	21.69	7.02	15.31	3.19	2.55	0.00	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	5.50	2.20	2.20	1.10	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	59.16	12.65	16.26	6.77	3.16	1.81	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	96.45	17.73	16.33	23.11	6.60	6.26	0.35	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	123.80	19.17	19.56	14.47	7.24	6.45	2.15	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	56.88	13.38	5.15	5.66	4.89	5.66	0.77	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	78.61	11.71	9.48	9.20	5.02	1.12	0.56	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	95.81	11.76	11.76	9.99	4.70	8.82	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	79.63	18.82	11.66	12.95	3.78	7.32	0.48	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	62.29	18.40	15.17	13.23	3.87	2.90	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	49.59	11.73	9.60	8.00	3.73	3.20	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	53.42	13.91	21.70	8.90	3.90	4.45	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	36.18	13.31	5.82	7.90	1.25	4.16	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	48.22	17.33	10.30	10.55	4.77	2.26	0.50	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	38.94	12.44	5.89	6.87	4.25	4.91	0.33	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	24.97	11.87	4.26	4.87	1.83	4.26	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	61.66	13.70	7.29	7.96	7.07	5.52	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	60.60	22.59	9.68	10.04	9.32	2.87	0.36	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	55.11	27.55	9.58	5.99	7.19	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	38.86	23.21	3.78	2.70	3.78	3.96	0.00	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	43.51	10.04	5.02	3.35	1.67	3.35	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	50.13	18.28	7.40	3.90	4.73	4.31	0.00	1.23
Anulus Pulposus Cell, donor1	11248-116E6	123.12	17.39	9.61	11.44	13.27	4.35	0.92	0.23
Anulus Pulposus Cell, donor2	11463-119B5	121.96	8.82	17.88	16.90	12.74	1.71	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	54.81	8.09	8.99	6.74	4.04	5.84	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	57.31	9.55	14.76	9.99	5.64	4.34	2.17	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	36.38	2.14	17.12	8.56	8.56	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	55.00	10.76	13.15	7.77	4.18	3.29	1.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	51.85	10.12	13.91	10.12	2.53	7.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	38.94	6.60	15.18	11.22	8.58	3.96	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	44.51	15.27	11.05	9.75	2.60	2.60	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	57.28	12.14	12.62	10.68	6.80	3.40	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	38.01	11.28	17.22	6.53	4.75	3.56	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	46.33	12.05	13.18	9.42	4.14	3.77	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	52.97	10.89	10.16	9.43	2.90	8.71	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	36.36	5.02	18.81	10.03	7.52	1.25	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	45.14	14.00	14.83	10.54	7.25	5.93	0.16	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	50.50	12.28	10.92	6.82	12.28	5.46	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	44.48	7.84	12.06	9.80	5.73	2.41	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	43.40	14.47	9.64	9.11	4.29	2.14	2.68	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	48.93	13.23	13.41	10.01	4.35	3.78	1.32	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	43.57	9.36	15.24	8.55	6.15	4.28	1.07	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	50.72	9.75	15.61	6.83	0.00	3.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	50.26	11.61	17.25	11.78	3.65	4.15	0.66	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	45.63	2.40	12.01	6.00	1.20	7.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	35.40	3.54	0.00	3.54	7.08	10.62	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	51.46	12.52	13.04	14.75	4.12	5.32	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	12.58	20.97	8.39	8.39	0.00	4.19	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	44.17	7.77	10.68	8.25	3.40	6.31	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	51.61	10.25	18.59	8.73	4.93	5.69	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	36.34	12.11	23.02	4.85	9.69	3.63	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	43.32	6.84	10.83	7.41	3.99	5.13	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	40.83	9.19	16.03	8.55	4.92	5.34	1.28	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	35.36	9.29	16.52	10.07	4.65	4.13	1.29	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	53.02	10.79	12.67	7.04	4.69	2.82	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	48.55	14.79	17.04	12.22	6.11	3.86	0.96	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	38.53	8.56	19.26	8.56	4.99	4.99	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	40.95	4.68	9.94	3.51	4.09	3.51	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	46.67	12.04	17.46	8.13	4.82	3.61	1.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	52.27	7.13	23.76	10.69	9.50	3.56	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	62.55	12.21	17.80	6.10	3.56	4.58	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	50.17	13.50	21.39	8.66	7.90	5.86	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	34.95	5.72	15.88	9.53	4.45	3.81	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	50.49	11.65	15.97	6.47	4.75	4.32	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	52.71	13.12	13.55	9.95	4.23	4.45	0.42	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	38.57	4.93	20.59	11.31	3.48	2.32	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	62.35	9.45	14.17	8.50	0.00	3.78	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	50.35	10.34	16.95	10.51	5.76	4.58	1.36	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	9.27	16.21	4.63	9.27	4.63	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	40.14	2.11	4.23	2.11	8.45	12.68	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	48.03	12.86	12.44	10.72	7.29	3.00	1.07	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	38.51	15.04	20.46	10.83	3.61	4.21	2.41	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	44.47	9.48	8.75	4.37	5.10	2.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	54.71	11.72	17.70	10.34	6.67	3.68	1.15	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	35.70	7.65	22.95	5.10	2.55	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	32.80	10.17	10.68	9.15	3.81	4.58	1.02	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	48.72	12.80	15.48	10.73	5.37	4.75	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	43.15	9.18	22.03	7.34	6.12	3.37	1.53	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	50.19	13.38	17.69	8.13	4.30	5.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	43.24	14.63	13.75	11.31	4.66	4.21	0.89	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	35.09	9.15	9.15	12.21	3.05	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	39.33	12.74	8.31	3.88	5.54	2.77	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	49.78	14.03	16.42	11.65	5.03	4.24	0.53	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	31.98	9.45	19.99	9.81	5.45	4.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	109.68	18.91	8.97	7.49	14.62	3.81	2.33	0.25
Astrocyte - cerebellum, donor2	11580-120F5	111.25	17.63	14.55	10.78	14.89	3.94	2.05	0.86
Astrocyte - cerebellum, donor3	11661-122F5	78.24	13.00	6.71	5.87	8.18	2.31	1.47	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	43.57	11.50	2.79	1.05	5.93	1.39	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	63.42	16.34	4.69	4.85	9.71	2.59	0.97	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	43.41	12.83	4.18	4.03	7.01	1.04	0.00	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	3.10	26.61	0.80	0.00	0.80	1.15	0.00	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	1.63	25.68	0.88	0.13	0.63	0.38	0.00	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	2.62	24.92	1.02	0.00	0.57	1.48	0.11	0.57
Basophils, donor1	12241-129G9	0.00	44.20	0.00	0.00	0.00	5.75	0.00	0.26
Basophils, donor2	12242-129H1	0.00	40.05	0.00	0.00	0.00	5.05	0.00	0.00
Basophils, donor3	12243-129H2	0.59	38.66	0.59	0.00	0.00	4.85	0.00	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	125.27	21.78	7.55	16.60	12.29	5.39	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	128.93	20.57	13.72	14.17	18.29	5.03	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	107.60	7.17	7.17	28.69	14.35	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	76.57	14.44	15.69	11.93	3.77	1.88	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	85.47	24.12	17.05	10.40	10.81	6.86	0.21	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	95.34	25.10	14.51	12.21	8.29	5.07	0.23	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	116.24	17.45	14.04	15.84	9.54	4.50	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	25.25	0.00	0.00	0.00	2.06	0.00	1.24
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	21.43	0.00	0.00	0.00	0.93	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	0.64	20.15	0.64	0.00	0.64	2.56	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	20.68	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	0.56	35.50	0.00	0.56	0.00	1.69	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	0.00	26.91	0.00	0.00	0.00	4.64	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	0.22	34.25	0.44	0.00	0.00	6.59	0.00	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	0.00	27.74	0.00	0.00	0.00	2.83	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	0.00	24.64	0.00	0.00	0.00	2.27	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	0.00	32.22	0.00	0.00	0.00	1.64	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	0.58	45.24	0.00	0.00	0.00	3.61	0.00	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	0.91	30.48	0.00	0.00	0.00	2.11	0.00	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	0.71	38.85	0.00	0.00	0.00	2.84	0.00	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.00	31.97	0.17	0.00	0.00	4.02	0.17	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.28	25.95	0.28	0.00	0.00	2.21	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.00	29.75	0.00	0.00	0.00	4.71	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.00	31.72	0.00	0.00	0.00	4.11	0.00	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.00	26.53	0.18	0.00	0.00	2.31	0.00	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.00	24.59	0.00	0.00	0.00	4.35	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.00	32.08	0.23	0.00	0.00	3.98	0.00	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	0.00	26.40	0.00	0.00	0.00	2.11	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	0.00	21.08	0.00	0.00	0.00	5.55	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.00	42.99	0.00	0.15	0.15	4.46	0.00	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.60	22.75	0.20	0.00	0.00	3.19	0.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.62	27.07	0.21	0.00	0.00	2.71	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.00	37.06	0.00	0.00	0.00	3.20	0.00	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.00	25.33	0.00	0.00	0.00	2.26	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.00	24.88	0.00	0.00	0.00	3.49	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.27	33.62	0.00	0.00	0.00	2.15	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.17	36.81	0.00	0.00	0.17	2.79	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.00	34.09	0.00	0.00	0.00	2.10	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.00	27.92	0.00	0.00	0.00	2.57	0.00	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.00	22.19	0.00	0.00	0.00	1.41	0.00	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.00	34.66	0.00	0.00	0.00	3.95	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.00	27.20	0.00	0.00	0.00	3.14	0.00	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.00	27.13	0.00	0.00	0.00	3.72	0.00	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.00	33.41	0.65	0.00	0.00	4.31	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	0.41	27.44	0.82	0.00	0.00	2.05	0.41	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.23	19.47	0.00	0.00	0.00	3.48	0.00	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.00	23.43	0.00	0.23	0.00	3.71	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.00	17.87	0.22	0.00	0.00	5.67	0.00	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	0.00	25.18	0.00	0.00	0.00	2.08	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	0.00	18.41	0.00	0.00	0.00	3.03	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	0.00	30.68	0.00	0.00	0.00	1.87	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	0.00	28.12	0.00	0.00	0.00	1.92	0.00	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	0.00	43.03	0.00	0.00	0.00	4.01	0.00	1.34
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	16.84	0.00	0.00	0.00	4.08	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	19.32	0.00	0.00	0.00	3.29	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	25.05	0.00	0.00	0.00	4.42	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	26.42	0.00	0.00	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	18.31	0.00	0.00	0.00	1.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	33.14	0.00	0.00	0.00	1.04	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.00	22.92	0.53	0.00	0.00	2.13	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.00	29.48	0.54	0.00	0.00	0.54	0.00	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.00	23.16	0.00	0.00	0.00	0.70	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.78	18.04	0.00	0.00	0.00	2.35	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	23.73	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	33.70	0.00	0.00	0.00	0.82	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	0.00	26.12	0.00	0.00	0.00	2.90	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.00	29.28	0.00	0.00	0.00	2.52	0.00	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.40	45.66	0.00	0.40	0.00	3.64	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.40	38.75	0.00	0.00	0.00	2.00	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	2.01	11.04	0.00	0.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	0.00	19.66	0.00	0.00	0.00	5.62	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	1.13	25.93	0.75	0.75	0.00	2.25	0.00	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	0.68	20.97	0.45	0.00	0.00	1.35	0.23	0.68
CD4+ T Cells, donor1	11225-116C1	0.00	46.06	0.00	0.00	0.00	13.57	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	0.00	42.87	0.00	0.00	0.00	7.35	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	0.00	42.09	0.00	0.00	0.00	7.62	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	28.84	0.00	0.00	0.00	1.53	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	31.67	0.00	0.00	0.00	1.35	0.00	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	35.65	0.00	0.00	0.00	1.15	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	24.18	0.00	0.00	0.00	2.37	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	25.99	0.00	0.00	0.00	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	32.96	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.43	29.34	0.00	0.00	0.00	2.75	0.00	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.00	26.27	0.17	0.00	0.00	2.03	0.00	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.00	24.66	0.00	0.00	0.00	3.06	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.00	21.07	0.00	0.00	0.00	4.48	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	23.06	0.00	0.00	0.00	2.10	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	43.12	0.00	0.00	0.00	5.28	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	22.77	0.00	0.00	0.00	3.79	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.00	29.92	0.00	0.00	0.00	2.70	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.00	24.73	0.00	0.00	0.00	1.34	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	33.18	0.00	0.00	0.00	4.08	0.00	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	40.73	0.00	0.00	0.00	4.82	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	28.69	0.00	0.00	0.00	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.00	36.16	0.00	0.00	0.00	3.71	0.00	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	31.41	0.00	0.00	0.00	2.82	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.00	44.34	0.00	0.00	0.00	4.20	0.00	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	29.33	0.00	0.00	0.00	7.08	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.00	28.16	0.00	0.00	0.00	3.47	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.00	45.32	0.00	0.00	0.00	6.10	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.00	44.54	0.00	0.00	0.00	3.46	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	31.39	0.00	0.00	0.00	3.69	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	32.10	0.00	0.00	0.00	4.19	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	0.00	38.49	0.00	0.00	0.00	2.77	0.00	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	0.00	36.56	0.00	0.00	0.00	3.19	0.00	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	29.26	0.00	0.00	0.00	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	0.00	47.27	0.00	0.00	0.00	1.79	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	36.01	0.00	0.00	0.00	1.38	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	0.00	45.84	0.00	0.00	0.00	11.46	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.00	44.68	0.00	0.00	0.00	10.51	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	0.00	39.64	0.00	0.00	0.00	11.61	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.82	13.30	2.06	0.69	0.23	1.15	0.69	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.12	14.62	1.92	0.00	0.72	0.96	0.24	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	2.19	15.32	1.37	0.00	0.55	1.09	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.20	14.41	0.90	0.30	0.30	2.40	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.64	16.80	1.44	0.72	0.24	1.44	0.24	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.32	14.55	0.91	0.00	0.91	1.14	0.23	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.00	11.08	1.74	0.43	1.52	0.87	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.95	13.95	1.05	0.00	1.58	1.05	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.22	10.79	0.94	0.47	0.70	1.17	0.23	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	8.75	9.36	1.51	0.60	3.02	1.81	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	4.65	9.88	2.03	0.00	1.45	0.58	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	3.20	9.33	3.20	0.53	0.27	0.53	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	6.57	9.63	2.19	1.75	2.19	2.19	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	6.38	9.11	3.19	0.91	0.46	0.46	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	9.70	6.71	0.00	2.24	0.00	0.75	1.49	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.04	15.85	1.80	0.00	1.44	2.16	0.72	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.89	10.36	0.58	0.58	0.29	2.30	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.01	12.02	0.71	0.00	1.18	1.65	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	3.17	8.87	0.95	0.00	1.90	2.22	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.00	9.53	1.54	0.00	0.31	3.08	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	2.56	8.98	1.28	0.00	0.00	1.60	0.96	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	3.82	14.92	1.91	0.00	0.76	2.29	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.55	10.64	1.18	0.00	0.79	1.97	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	0.76	11.35	5.29	0.00	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	8.03	20.07	0.00	2.41	0.80	0.80	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	4.90	13.29	2.10	1.40	0.70	2.10	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	12.02	14.02	3.01	1.00	0.00	3.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	235.78	18.28	34.73	31.07	18.28	12.79	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	77.57	16.30	11.36	6.42	6.92	2.96	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	80.92	18.94	6.10	8.84	4.53	6.73	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	62.05	14.21	9.36	7.63	4.16	3.12	1.39	0.35
Chondrocyte - de diff, donor2	11338-117F6	53.66	16.70	4.98	5.33	6.75	3.91	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	67.47	12.63	8.31	9.10	4.44	3.64	0.46	0.23
Chondrocyte - re diff, donor2	11339-117F7	20.59	12.53	2.69	2.69	2.69	5.37	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	43.27	20.22	6.07	2.83	5.26	4.85	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	97.09	25.82	9.30	6.89	14.00	5.62	0.46	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	111.37	14.54	10.05	11.54	14.32	3.42	0.64	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	108.68	17.17	8.14	10.71	11.42	3.72	1.24	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	10.55	30.44	1.10	0.55	1.28	3.48	0.28	0.37
Corneal Epithelial Cells, donor1	11526-119I5	175.44	29.42	16.03	19.98	15.81	5.71	0.44	0.66
Corneal Epithelial Cells, donor2	11606-120I4	46.64	22.75	12.51	11.38	5.69	6.83	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	72.09	21.73	12.27	13.29	8.69	4.60	0.26	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1.98	29.06	0.66	0.17	0.50	1.98	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	1.58	32.80	1.58	0.32	0.00	1.89	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	13.80	10.35	0.00	0.00	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	0.76	24.73	1.08	0.11	0.11	0.86	0.11	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	0.00	41.34	0.00	0.00	0.00	1.37	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.00	33.30	0.00	0.00	0.00	3.92	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.00	26.13	0.00	0.00	0.00	0.48	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	39.02	18.01	8.17	4.34	3.34	12.34	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	38.14	9.98	7.63	4.11	6.45	8.80	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	78.62	20.93	8.77	8.77	5.66	11.03	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	27.13	9.83	3.54	4.33	4.72	14.55	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	63.41	13.38	4.36	9.31	5.24	13.38	0.29	0.58
Endothelial Cells - Artery, donor2	11341-117F9	66.11	21.88	6.35	6.82	8.94	12.71	1.18	0.24
Endothelial Cells - Artery, donor3	11413-118E9	50.84	19.99	6.49	5.79	7.01	12.45	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	56.74	10.64	5.98	5.98	5.10	8.20	0.66	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	62.68	11.87	6.69	7.61	3.65	8.22	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	51.31	14.66	3.95	5.07	4.23	5.92	0.56	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	57.05	16.94	7.13	3.57	5.65	8.02	0.59	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	63.00	8.85	4.69	8.85	3.64	6.77	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	47.22	20.13	5.10	5.25	3.40	7.09	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	91.63	15.20	10.40	8.80	5.60	12.00	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	84.38	13.63	6.81	9.43	9.43	6.29	1.57	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	97.04	21.37	11.43	6.96	13.79	11.68	0.75	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	75.39	11.51	6.74	6.08	7.60	7.60	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	63.63	13.68	4.52	7.33	7.33	8.67	0.49	0.12
Endothelial Cells - Vein, donor1	11267-116G7	45.50	7.96	5.69	4.55	6.83	4.55	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	53.78	11.87	4.89	4.19	6.29	13.97	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	49.61	17.90	8.01	3.77	5.18	10.83	0.31	0.00
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	47.86	0.00	0.00	0.00	19.80	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	49.94	0.00	0.00	0.00	21.40	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	130.71	20.28	8.06	11.97	12.95	3.66	0.24	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	89.45	14.56	4.16	20.80	6.24	4.16	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	32.54	16.27	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	53.37	9.85	17.65	8.62	2.46	4.11	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	36.57	4.16	15.33	11.39	3.39	2.08	0.33	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	56.34	12.35	12.13	8.23	4.77	4.98	0.87	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	63.07	15.65	13.22	8.73	4.85	4.85	0.49	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	100.58	15.69	9.83	12.15	9.01	7.37	4.23	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	66.97	14.13	13.82	13.92	7.49	4.43	0.84	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	69.56	11.86	6.85	6.06	10.54	5.27	2.11	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	58.13	15.28	7.97	7.64	5.98	4.65	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	57.61	12.25	13.16	9.53	5.44	3.63	1.36	0.00
Fibroblast - Cardiac, donor2	11345-117G4	61.39	15.92	14.40	6.82	3.79	5.31	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	56.62	14.35	14.19	11.04	3.94	3.31	0.16	0.32
Fibroblast - Cardiac, donor4	11452-119A3	109.42	23.04	11.21	12.73	7.88	6.97	1.21	0.61
Fibroblast - Cardiac, donor5	11456-119A7	58.76	13.83	11.42	4.31	6.47	5.84	0.63	0.25
Fibroblast - Cardiac, donor6	11460-119B2	47.75	14.55	13.19	7.73	4.85	6.22	0.76	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	85.89	15.81	11.39	8.44	7.24	6.97	0.94	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	67.73	11.65	11.65	7.33	3.88	5.61	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	39.55	21.97	13.18	1.46	11.72	4.39	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	114.86	32.52	5.30	6.46	11.99	7.61	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	56.31	19.33	4.92	3.90	3.22	3.73	0.17	0.68
Fibroblast - Dermal, donor1	11269-116G9	93.44	12.21	13.38	20.43	11.97	6.57	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	50.94	19.81	7.08	3.77	5.19	10.85	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	59.72	16.56	7.98	7.74	5.44	4.47	0.73	0.36
Fibroblast - Dermal, donor4	11450-119A1	42.73	14.81	7.57	4.18	5.99	2.15	0.90	0.45
Fibroblast - Dermal, donor5	11454-119A5	37.16	14.31	9.25	2.09	4.88	2.97	2.09	0.00
Fibroblast - Dermal, donor6	11458-119A9	47.91	13.81	10.07	3.25	7.63	4.06	2.76	0.97
Fibroblast - Gingival, donor1	11237-116D4	110.99	18.32	13.95	13.12	14.78	5.83	0.83	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	65.76	18.60	18.08	11.27	7.60	6.03	1.57	0.00
Fibroblast - Gingival, donor2	11318-117D4	74.85	19.37	7.64	7.25	10.94	2.77	0.79	0.92
Fibroblast - Gingival, donor3	11394-118C8	114.57	19.72	10.93	12.18	10.06	4.54	1.35	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	104.93	11.43	17.66	9.35	9.35	3.12	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	61.14	14.10	9.51	8.46	3.88	2.47	0.53	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	51.13	23.38	12.63	6.39	5.92	5.92	1.56	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	45.98	21.64	11.09	6.90	7.17	4.60	1.49	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	71.99	22.23	22.23	14.12	7.41	5.65	1.76	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	45.34	15.36	9.80	7.17	7.17	3.66	1.46	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	41.18	16.64	8.04	6.82	6.54	3.00	1.64	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	34.11	18.32	9.32	4.28	4.39	5.70	0.66	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	50.18	15.70	7.04	2.05	4.55	1.91	1.32	0.29
Fibroblast - Lung, donor1	11270-116H1	54.37	17.67	6.80	8.16	9.52	9.52	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	53.72	8.95	1.49	2.98	5.97	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	75.76	20.68	9.92	6.75	8.02	4.01	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	149.11	36.65	13.33	17.49	16.66	16.66	3.33	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	74.13	9.79	13.99	9.79	6.99	8.39	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	81.44	15.11	11.75	10.08	11.75	8.40	0.84	0.00
Fibroblast - Mammary, donor1	11540-120B1	134.78	34.91	8.12	14.61	11.77	21.52	1.62	0.41
Fibroblast - Mammary, donor2	11620-122A9	83.88	11.98	11.98	11.98	19.97	15.98	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	89.34	11.91	0.00	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	58.19	20.56	5.82	2.91	6.21	3.69	0.97	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	63.55	20.93	8.80	5.01	10.47	3.64	1.52	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	106.48	23.87	9.18	11.32	10.71	8.26	1.22	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	56.10	19.84	8.78	5.34	8.78	3.05	1.91	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	69.93	17.55	15.93	11.07	7.83	4.86	0.81	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	58.10	13.34	8.12	7.19	4.29	3.02	0.12	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	50.73	14.59	8.84	7.41	4.64	5.08	0.33	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	110.74	38.20	11.38	13.21	11.18	12.39	0.20	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	52.79	19.38	8.69	4.01	4.68	4.01	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	51.00	15.42	6.72	3.56	5.14	5.93	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	76.40	22.42	10.91	6.75	6.75	11.11	3.37	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	64.83	15.99	6.22	5.86	3.73	3.37	1.24	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	67.21	18.92	7.10	6.90	4.34	5.32	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	63.48	22.56	8.72	4.81	6.32	8.12	3.31	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	75.46	18.14	10.47	6.37	4.32	5.29	1.73	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	112.11	17.97	13.92	11.14	8.35	9.36	6.83	0.76
Fibroblast - skin normal, donor1	11553-120C5	86.14	18.38	8.70	8.70	3.45	5.91	1.15	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	84.81	29.07	5.61	6.22	10.23	8.62	2.21	0.60
Fibroblast - skin normal, donor2	11561-120D4	60.78	15.87	17.68	8.64	4.32	4.62	1.21	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	73.14	21.46	9.07	3.93	6.65	4.84	4.53	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	64.87	19.22	8.45	5.22	3.40	4.39	1.16	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	67.87	17.27	6.15	7.01	3.59	3.93	0.85	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	70.61	15.76	9.85	4.60	5.91	6.24	2.63	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	64.77	16.83	14.06	8.73	5.33	5.11	0.75	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	78.61	18.39	9.61	11.30	5.06	5.57	1.01	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	53.32	13.17	11.92	8.00	2.98	2.51	0.31	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	66.48	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	12.20	17.43	1.74	3.49	0.87	3.49	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	65.88	19.24	13.18	14.04	6.41	5.55	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	88.22	24.46	16.66	22.38	10.67	5.73	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	79.21	26.57	16.35	21.46	8.69	5.88	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	49.76	8.42	1.53	5.36	13.01	1.53	3.06	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	43.39	13.40	5.10	3.19	11.49	0.64	1.28	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	77.88	16.55	5.13	6.85	17.12	0.86	5.42	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	50.46	12.41	1.65	1.10	5.24	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	49.32	8.68	3.20	4.34	14.38	0.46	0.68	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	94.31	14.27	4.56	7.53	15.85	0.20	3.96	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	42.29	8.46	1.59	1.85	8.99	0.53	0.53	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	46.64	8.81	2.61	3.59	11.74	0.00	0.00	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	64.12	11.94	3.98	9.29	21.23	1.77	3.54	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	45.36	14.70	1.84	1.84	7.07	0.57	0.85	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	64.90	12.68	2.09	4.19	6.16	0.37	0.74	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	34.92	15.04	3.76	6.45	6.45	0.54	1.07	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	79.79	22.55	3.35	6.07	10.28	1.12	1.73	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	58.83	16.75	2.77	3.88	7.06	0.83	0.83	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	40.05	14.84	3.05	4.47	8.54	0.81	1.02	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	78.49	18.48	6.16	6.85	11.41	2.28	0.46	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	60.91	21.30	3.49	3.49	7.10	1.25	1.00	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	53.33	22.08	5.90	5.25	9.40	0.87	1.31	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	64.71	14.18	4.73	3.55	8.27	2.36	1.18	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	58.66	13.51	2.54	2.54	4.77	0.16	0.79	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	52.73	18.10	2.90	3.35	6.03	2.90	0.67	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	54.64	14.52	4.44	3.23	8.07	1.41	0.40	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	57.68	15.44	2.04	2.88	5.94	1.02	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	61.89	22.88	6.30	3.99	7.36	2.93	1.06	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	97.19	23.93	4.06	2.91	13.84	2.71	0.73	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	87.95	17.08	4.61	2.56	8.88	1.37	1.02	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	51.01	13.39	2.21	2.21	5.64	1.11	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	55.24	18.30	3.74	3.08	6.32	2.25	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	55.74	18.38	3.27	2.86	7.96	1.84	0.82	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	66.22	13.62	4.54	2.27	10.11	1.44	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	63.18	16.26	3.34	1.15	8.53	1.38	0.35	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	52.86	16.68	6.00	2.50	6.00	2.00	0.83	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	60.18	15.65	5.29	1.54	6.39	2.42	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	68.26	17.71	3.81	2.58	7.87	1.23	0.61	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	51.87	11.67	4.05	3.40	5.19	0.97	0.65	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	58.69	13.79	4.81	0.96	9.30	1.92	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	55.72	16.58	3.32	2.27	7.01	1.23	0.47	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	46.50	14.71	4.90	2.69	5.06	1.74	0.47	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	60.21	11.25	5.47	3.65	6.08	2.74	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	62.20	16.52	4.08	2.93	6.17	1.46	0.63	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	42.37	13.17	3.73	2.42	5.71	2.20	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	50.78	12.34	3.65	2.81	6.45	1.68	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	42.68	17.22	3.24	2.04	4.35	1.20	0.37	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	33.43	14.97	5.35	1.87	5.08	1.87	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	45.75	13.16	5.51	3.37	5.05	2.75	0.77	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	39.64	14.51	3.89	2.20	4.27	1.94	0.39	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	33.61	12.47	7.32	2.98	4.07	1.63	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	60.28	12.90	8.66	4.61	8.48	3.87	1.66	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	60.31	14.47	5.48	4.17	9.43	3.07	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	49.59	18.84	3.97	0.99	1.98	2.98	1.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	67.54	14.11	12.53	5.28	5.14	4.09	0.79	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	67.99	12.31	7.87	5.04	6.25	4.04	1.01	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	73.96	37.62	3.05	2.80	10.93	6.35	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	52.55	16.12	1.39	3.38	6.77	0.80	2.79	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	62.71	14.02	0.62	2.62	6.01	0.77	1.23	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	51.35	21.69	0.82	1.64	6.14	0.41	2.05	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	31.61	10.64	2.82	2.19	5.95	0.31	0.63	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	22.89	7.35	3.39	2.26	4.80	0.28	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	20.75	11.99	0.46	2.77	4.61	0.00	1.84	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	19.80	22.27	0.00	2.47	4.95	0.00	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	26.30	14.31	2.32	2.71	5.03	0.77	3.48	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	17.65	6.42	0.00	1.60	3.21	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	45.21	10.43	5.22	3.48	6.96	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	22.46	10.09	2.60	0.65	2.60	0.33	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	25.12	11.53	0.82	1.65	4.53	0.00	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	6.66	0.00	0.00	10.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	17.90	9.51	1.68	1.68	3.36	1.12	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	17.32	10.13	2.29	2.61	2.94	0.00	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	26.00	9.23	0.84	0.00	0.00	0.00	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	19.72	12.09	1.27	0.64	3.50	0.00	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	20.04	13.93	1.70	0.68	3.06	1.02	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	10.44	0.00	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	26.92	13.17	2.29	0.57	5.73	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	15.39	6.81	1.48	0.89	2.37	0.89	0.59	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	11.86	8.47	0.00	1.69	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	24.85	12.01	2.49	2.07	2.49	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	19.56	7.13	2.07	0.69	2.30	0.69	0.46	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	10.54	0.00	5.27	5.27	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	17.30	9.99	1.92	2.69	1.15	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	15.97	4.89	1.30	1.96	2.61	0.33	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	25.42	5.35	0.67	0.00	1.34	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	23.89	8.09	0.39	0.77	3.47	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	26.70	18.49	2.40	0.34	3.42	1.37	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	52.18	2.48	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	21.71	3.77	0.47	0.47	2.36	0.00	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	17.50	6.03	1.21	0.00	1.81	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	27.47	7.12	0.51	0.51	3.05	1.02	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	25.92	8.38	1.60	0.80	3.59	0.40	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	32.56	7.89	2.47	0.49	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	35.41	3.54	1.18	3.54	7.08	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	29.76	5.25	0.58	0.58	1.75	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	31.16	9.22	0.44	1.76	4.83	1.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	29.67	5.93	0.85	0.00	5.93	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	20.89	10.15	2.98	1.19	3.58	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	15.04	9.22	0.00	1.46	2.43	1.94	0.00	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	108.42	17.12	11.41	14.84	6.85	10.27	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	92.73	24.12	19.13	17.46	7.48	4.57	0.83	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	88.83	22.49	17.99	15.74	10.12	3.37	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	72.31	16.81	16.81	15.22	7.93	7.61	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	93.57	12.11	28.41	25.90	7.52	3.76	0.84	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	17.99	22.40	3.02	1.16	3.48	2.55	0.35	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	17.05	23.46	1.18	1.01	3.88	3.88	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	13.65	26.16	1.37	0.68	2.28	3.64	0.46	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	15.41	27.00	2.40	1.75	4.26	2.51	0.33	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	15.69	28.37	2.58	1.50	3.87	3.87	0.21	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	16.58	22.17	1.72	0.86	2.37	4.52	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	17.19	21.92	2.86	1.37	3.11	3.36	0.37	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	16.98	15.95	1.89	0.69	2.74	3.60	1.03	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	14.42	24.03	2.24	0.64	1.60	4.49	0.00	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	78.91	11.19	13.99	8.95	7.83	7.28	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	75.74	16.01	14.71	7.79	9.95	6.92	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	15.86	2.64	10.58	7.93	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	117.46	24.34	8.47	10.23	13.40	7.76	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	70.47	23.97	13.80	7.99	7.99	3.63	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	53.50	12.41	8.22	8.04	4.55	7.17	0.87	0.00
Hepatocyte, donor1	11523-119I2	0.00	41.16	1.21	0.00	0.00	7.26	0.00	0.00
Hepatocyte, donor2	11603-120I1	16.16	42.02	1.08	0.00	0.00	8.62	0.00	1.08
Hepatocyte, donor3	11684-122I1	21.47	36.20	5.52	1.23	2.45	7.98	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	23.50	0.00	0.00	0.00	1.31	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	8.21	23.95	0.35	0.17	1.05	3.67	0.00	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	101.81	14.27	11.25	14.68	12.62	3.98	0.96	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	28.66	0.00	0.00	6.37	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	26.70	0.00	0.00	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	13.84	19.38	0.00	0.00	0.00	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	20.02	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	41.01	0.00	0.00	7.69	2.56	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	32.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	21.12	1.62	0.00	1.62	6.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	25.01	0.00	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	25.41	3.63	0.00	3.63	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	10.59	23.82	3.97	0.00	3.97	5.29	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	22.17	0.00	1.11	2.22	3.33	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	10.48	0.00	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3.15	20.79	0.00	0.63	0.00	1.89	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	21.65	0.00	0.00	4.64	3.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	6.46	27.13	1.29	0.00	1.94	4.52	1.94	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	24.15	0.00	0.00	3.22	1.61	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	23.90	0.00	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	9.78	25.26	0.00	0.00	2.44	3.26	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	6.30	29.39	1.26	0.42	2.52	2.52	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	28.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	11.25	33.75	1.61	0.00	0.00	2.41	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	5.54	30.47	0.00	0.00	1.85	1.85	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	5.66	22.66	0.94	0.00	0.94	3.30	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	8.16	19.95	0.91	0.91	1.81	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	12.91	27.98	2.15	1.08	3.23	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	16.52	30.49	1.27	1.27	2.54	1.27	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	7.65	24.87	0.64	0.64	3.19	3.83	1.28	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	30.99	0.00	0.00	3.65	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	31.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	4.28	28.56	2.86	0.00	1.43	6.43	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	33.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.17	18.52	0.62	0.62	0.93	2.47	0.31	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	12.29	0.00	0.00	5.27	5.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	18.86	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	10.43	27.82	0.00	0.00	2.78	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	30.98	0.00	0.00	2.21	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	6.48	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	8.72	32.26	0.87	1.74	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	33.75	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	27.88	0.00	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	27.74	1.07	0.00	1.07	3.20	1.07	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	4.16	19.40	0.00	2.77	2.77	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	14.25	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	9.20	23.93	0.00	0.00	1.84	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	27.23	0.00	0.00	0.00	6.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	37.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	44.41	1.06	1.06	0.00	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	99.55	20.07	24.81	25.21	15.99	7.18	0.57	0.08
Keratinocyte - epidermal, donor2	11349-117G8	80.82	23.43	13.47	10.54	8.78	5.27	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	37.39	20.82	10.89	3.50	4.35	3.50	0.57	0.38
Keratinocyte - oral, donor1	11251-116E9	242.93	38.60	29.97	27.70	20.66	6.36	0.45	0.91
Keratocytes, donor1	11527-119I6	131.69	35.41	2.75	5.85	6.53	4.13	0.69	0.34
Keratocytes, donor2	11607-120I5	71.48	11.72	11.72	8.20	7.03	5.86	0.00	0.00
Keratocytes, donor3	11688-122I5	63.82	22.53	5.53	3.56	3.36	3.56	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	17.58	17.58	0.00	2.20	2.20	6.59	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	79.83	15.10	3.24	11.87	3.24	4.31	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	111.41	15.69	4.04	7.84	9.80	1.96	0.23	0.23
Lens Epithelial Cells, donor3	11690-122I7	111.30	13.02	11.91	15.34	9.59	4.64	0.40	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	62.37	20.04	11.26	7.35	5.34	11.98	0.59	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	30.70	15.35	8.09	5.86	5.02	5.02	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	48.17	16.21	9.44	6.61	6.30	7.40	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	34.41	9.68	4.84	5.38	2.15	4.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	32.15	14.81	8.82	6.62	2.84	6.62	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	44.53	13.58	12.29	5.18	3.99	5.71	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	38.99	8.21	4.92	4.92	4.10	8.62	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	38.93	11.12	8.09	5.81	7.33	7.33	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	43.63	13.37	9.29	5.77	4.22	8.02	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	35.60	8.31	3.96	2.77	3.16	4.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	46.14	14.93	9.50	5.04	6.59	6.01	0.39	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	46.66	14.07	9.63	6.67	5.18	7.78	0.56	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	39.02	13.24	8.36	5.57	3.14	4.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	45.08	17.17	8.11	7.16	5.72	9.06	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	46.70	13.32	9.34	6.18	4.40	9.89	0.41	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	40.65	11.39	5.24	4.00	5.54	6.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	33.67	10.91	6.55	5.92	4.68	7.48	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	51.24	17.38	9.52	5.67	5.86	8.78	0.73	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	42.46	10.86	4.94	6.91	5.27	7.57	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	45.40	16.11	7.03	4.69	5.56	7.03	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	45.31	17.18	11.95	6.47	6.47	9.96	0.75	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	38.31	9.21	10.18	3.88	9.70	3.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	45.24	12.39	10.23	5.39	4.04	9.96	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	40.87	11.05	8.93	7.11	4.54	10.29	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	32.14	6.22	6.74	4.15	4.15	7.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	42.51	14.45	8.79	6.91	5.86	7.33	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	47.82	16.09	10.53	8.57	4.66	8.87	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	45.40	4.82	8.94	9.63	3.44	5.50	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	42.52	13.36	7.90	5.83	7.15	5.64	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	45.80	13.57	10.18	7.10	3.50	7.10	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	44.58	15.99	6.30	6.78	5.81	2.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	43.66	13.89	5.95	3.64	5.62	5.95	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	41.50	12.14	9.91	5.45	4.71	7.56	0.12	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	54.05	11.11	5.92	3.33	4.44	10.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	40.77	11.86	5.44	4.20	5.93	4.69	0.49	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	44.82	12.51	8.94	7.29	5.09	7.84	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	39.56	12.22	7.40	6.11	4.18	7.08	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	36.22	11.26	7.91	4.87	4.56	7.61	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	46.75	12.04	10.92	4.90	4.90	6.30	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	31.64	10.31	6.76	6.76	3.20	4.62	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	35.87	13.57	7.76	3.88	6.79	9.21	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	41.08	15.41	8.71	7.31	4.20	6.69	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	42.26	15.04	6.80	9.67	2.51	9.31	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	42.47	15.03	4.90	5.23	3.92	6.86	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	41.67	14.13	6.36	4.47	4.71	7.06	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	74.75	20.91	10.02	11.26	4.08	10.40	0.62	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	42.26	13.57	8.45	5.89	3.59	6.92	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	44.46	12.53	8.06	5.97	3.88	8.06	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	15.86	0.00	0.00	0.00	6.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	4.60	23.01	0.00	0.00	0.00	2.30	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.00	18.56	0.00	0.00	0.00	2.97	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	2.54	23.27	0.00	0.00	0.00	8.04	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	1.41	22.51	0.70	0.00	0.00	5.63	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	1.87	23.35	0.00	0.93	0.00	6.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.52	25.76	0.00	0.00	0.52	3.09	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1.19	36.87	0.00	0.00	0.00	1.19	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	1.13	28.50	0.00	0.23	0.00	4.52	0.00	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	0.87	24.14	0.00	0.29	0.00	3.20	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	0.90	26.11	0.00	0.00	0.90	6.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	1.22	37.39	0.14	0.14	0.27	6.23	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	2.05	22.08	0.51	0.00	0.00	5.65	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	1.06	26.82	0.71	0.00	0.35	5.29	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	1.33	26.65	0.00	0.00	0.00	3.33	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	0.51	19.36	0.00	0.00	0.00	4.08	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1.07	28.01	0.00	0.27	0.00	6.67	0.00	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	1.32	26.07	0.00	0.00	0.19	5.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	2.45	23.32	0.00	0.00	0.00	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	0.82	27.72	0.00	0.00	0.00	8.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	0.83	27.28	0.00	0.00	0.42	4.16	0.00	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	1.40	18.50	0.00	0.00	0.28	2.52	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	2.06	22.67	0.00	0.00	0.00	6.18	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	1.16	29.32	0.00	0.00	0.29	4.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	0.60	18.23	0.00	0.00	0.00	4.48	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1.11	23.24	0.00	0.00	0.00	6.09	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	1.41	38.88	0.00	0.00	0.35	3.53	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	1.48	19.91	0.00	0.37	0.74	4.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	2.30	24.18	0.00	0.00	0.00	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	1.15	30.32	0.00	0.00	0.00	3.45	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	0.57	22.65	0.00	0.00	0.00	3.40	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.82	23.79	0.00	0.00	0.00	5.74	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	1.36	28.92	0.00	0.90	0.00	4.97	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	1.44	25.14	0.00	0.00	0.00	4.31	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	0.75	21.66	0.00	0.00	0.00	5.98	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	0.37	30.10	0.00	0.37	0.00	5.95	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	1.29	16.80	0.00	0.43	0.43	1.29	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.00	31.68	0.00	0.00	0.00	3.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	0.67	26.32	0.33	0.00	0.00	4.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	1.81	19.31	0.00	0.00	0.00	6.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	0.71	25.60	0.00	0.00	0.00	2.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	0.69	26.12	0.00	0.00	0.00	2.41	0.00	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	0.54	19.86	0.00	0.00	0.00	1.07	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	1.35	26.26	0.00	0.00	0.67	2.69	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	1.85	21.11	0.00	0.37	0.00	4.82	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	2.33	18.61	0.00	0.00	1.16	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	3.17	27.50	0.00	1.06	2.12	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	0.40	33.21	0.00	0.00	0.40	4.80	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	0.73	19.63	0.00	0.00	0.00	5.09	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	3.07	29.13	0.77	0.00	0.77	6.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	0.00	30.09	0.00	0.49	0.49	5.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.94	19.76	0.00	0.00	0.00	2.82	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	2.01	28.16	1.01	0.00	0.00	4.53	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	0.45	25.23	0.45	0.45	0.00	6.31	0.45	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	20.65	0.00	0.00	0.00	5.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	3.12	37.85	0.45	0.00	0.00	4.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	1.96	26.20	0.39	0.00	0.39	5.08	0.00	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	0.66	19.79	0.00	0.66	0.66	5.28	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	1.04	30.10	0.00	0.00	0.00	7.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	1.31	32.38	1.31	0.00	0.88	7.00	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	2.24	20.69	0.00	0.00	0.56	2.80	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	3.53	30.47	0.00	0.00	0.00	8.83	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	1.54	33.94	0.00	0.39	0.00	5.79	0.00	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	2.03	19.24	0.51	0.00	0.00	3.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1.44	31.24	0.00	0.00	0.48	6.73	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	0.80	27.03	0.00	0.40	0.00	4.77	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	0.00	15.80	0.00	0.00	0.00	3.04	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	0.69	17.98	0.00	0.00	0.00	6.23	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	2.66	29.64	0.00	0.00	0.00	7.22	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	1.03	23.76	1.03	0.00	0.52	8.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	2.42	22.37	0.00	0.00	0.00	4.23	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	1.90	27.57	0.32	0.00	0.00	8.24	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	1.60	24.52	0.00	0.00	1.07	2.67	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	2.87	23.56	0.00	0.00	0.57	6.32	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	3.60	42.17	0.00	0.00	0.00	8.23	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	2.12	29.71	0.00	0.00	0.00	6.37	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	1.13	29.51	0.00	0.57	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	2.08	34.11	0.00	0.42	0.42	8.32	0.00	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	0.78	32.89	0.00	0.00	0.00	6.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	1.25	18.79	0.00	0.00	0.00	5.85	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	1.39	36.24	0.00	0.00	0.00	8.36	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	2.01	24.09	0.67	0.00	0.67	8.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	0.53	20.32	0.00	0.00	0.00	5.88	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	2.83	28.29	0.00	0.00	0.00	7.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	2.75	17.44	0.00	0.00	0.00	1.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	4.45	21.34	0.00	0.00	0.89	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	1.14	36.47	0.00	0.00	1.14	4.56	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	1.53	25.31	0.77	0.00	0.00	3.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	0.55	21.34	0.00	0.00	0.55	2.19	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	4.90	24.05	0.00	0.00	0.45	4.01	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	4.42	35.35	0.52	0.26	0.26	5.72	0.00	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	3.32	25.20	0.66	0.00	0.00	3.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	35.34	0.00	0.00	2.08	12.47	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	0.00	20.51	0.00	0.00	0.00	1.37	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	0.00	17.62	0.18	0.00	0.00	0.92	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	0.26	22.41	0.00	0.00	0.00	1.84	0.00	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	42.48	14.34	5.31	7.43	4.78	2.66	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	64.81	15.53	16.48	12.36	4.91	4.44	0.63	0.16
Mallassez-derived cells, donor3	11930-125I4	58.10	15.84	12.37	13.62	6.39	5.14	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	149.07	34.68	18.23	27.10	16.84	8.87	0.80	0.70
Mammary Epithelial Cell, donor2	11350-117G9	152.88	21.43	11.87	20.56	16.50	5.21	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	62.61	22.95	6.73	8.98	7.73	5.24	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	1.36	71.18	0.00	0.00	0.68	18.30	0.00	0.68
Mast cell, donor1	11563-120D6	4.87	34.71	1.19	0.11	0.76	6.06	0.11	0.22
Mast cell, donor2	11565-120D8	1.78	55.27	0.59	0.00	0.30	9.81	0.00	0.30
Mast cell, donor3	11566-120D9	1.58	61.46	0.00	0.45	0.23	8.78	0.23	0.23
Mast cell, donor4	11567-120E1	1.60	53.36	0.53	0.00	0.35	11.17	0.00	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	3.99	30.27	1.55	0.22	0.89	3.22	0.33	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	5.25	36.77	2.92	0.00	1.75	5.84	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	3.44	29.83	1.03	0.00	0.57	2.98	0.00	0.34
Mast cell, expanded, donor8	11941-126A6	4.52	28.79	1.34	0.00	0.33	3.18	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	112.83	16.22	21.39	15.62	8.66	10.85	0.40	0.10
Melanocyte - dark, donor2	11582-120F7	75.79	14.54	11.42	13.15	7.96	4.50	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	9.63	25.14	1.59	0.72	1.09	2.10	0.00	0.43
Melanocyte - light, donor1	11274-116H5	24.21	22.57	3.06	2.12	1.65	2.35	0.24	0.47
Melanocyte - light, donor2	11351-117H1	11.60	16.38	2.73	2.73	2.05	2.73	0.00	0.00
Melanocyte - light, donor3	11423-118G1	19.08	13.01	8.67	2.60	0.87	3.47	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	21.14	18.33	2.50	0.83	2.29	1.87	0.00	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	23.94	14.79	5.38	2.69	3.50	2.15	0.27	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	30.54	12.32	2.95	1.61	3.21	1.87	0.27	0.00
Meningeal Cells, donor1	11493-119E8	86.47	23.08	9.92	6.20	8.56	12.28	0.74	0.12
Meningeal Cells, donor2	11573-120E7	38.73	13.20	6.16	4.40	5.28	5.72	1.32	0.44
Meningeal Cells, donor3	11654-122E7	54.12	19.72	8.64	5.79	8.88	10.84	0.73	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	97.24	17.39	9.12	8.27	14.26	5.99	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	48.91	10.47	8.15	7.85	4.23	3.42	0.81	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	180.04	10.51	22.34	19.71	17.08	10.51	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	77.18	17.01	14.39	15.70	19.62	7.85	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	45.21	10.76	12.92	5.74	3.59	6.46	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	64.80	14.82	7.20	9.11	4.02	4.24	1.27	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	50.77	7.54	11.06	6.53	3.52	4.02	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	97.79	21.98	7.25	10.33	10.33	10.11	1.76	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	59.91	13.88	5.11	10.23	9.50	6.58	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	95.14	16.57	15.35	17.19	11.66	6.75	1.84	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	113.85	13.71	11.63	10.67	9.14	4.57	0.69	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	124.90	32.71	8.55	13.75	7.06	8.55	0.74	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	99.60	18.82	10.79	7.76	7.24	5.53	0.79	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	133.83	13.95	3.56	9.20	6.23	6.53	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	84.08	9.34	9.34	7.01	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	87.09	15.37	7.68	12.17	12.81	3.20	3.84	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	54.23	18.43	6.03	7.80	6.03	6.03	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	103.82	21.89	10.95	5.63	6.57	4.69	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	59.51	10.89	7.98	8.71	5.81	5.81	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	84.33	11.93	10.61	12.99	7.16	1.59	0.53	0.00
Mesothelial Cells, donor2	12156-128G5	73.07	8.51	13.01	18.02	3.50	2.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	77.47	11.13	10.55	14.60	6.43	3.40	0.43	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	1.35	32.41	0.00	0.00	0.00	4.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	0.00	20.93	0.49	0.00	0.00	1.48	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	0.00	18.85	0.00	0.00	0.00	0.29	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	0.00	14.88	0.00	0.00	0.00	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	0.21	19.08	0.21	0.00	0.00	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	9.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	0.50	22.77	0.00	0.00	0.00	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	0.00	22.34	0.00	0.00	0.00	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	0.20	19.51	0.00	0.00	0.00	1.42	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	0.00	23.36	0.00	0.00	0.00	2.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.00	11.50	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	0.00	19.38	0.00	0.00	0.00	1.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	10.53	0.00	0.00	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	0.00	14.86	0.00	0.00	0.00	0.85	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.00	11.05	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	0.00	12.52	0.00	0.00	0.60	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	18.44	0.00	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	0.00	17.56	0.00	0.00	0.00	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	0.24	12.83	0.00	0.00	0.00	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.00	7.74	0.00	0.00	0.55	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	0.00	17.73	0.00	0.00	0.00	1.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	0.00	13.88	0.00	0.00	0.00	1.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	0.00	16.51	0.00	0.00	0.00	1.02	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	0.00	16.52	0.00	0.00	0.00	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	0.00	14.45	0.00	0.00	0.00	0.89	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.00	17.30	0.00	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.51	12.67	0.00	0.00	0.00	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	11.60	0.00	0.00	0.00	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	0.00	12.23	0.00	0.00	0.00	1.36	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	0.00	16.47	0.29	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	8.72	0.00	0.00	0.00	4.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.00	8.65	0.00	0.00	0.00	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	0.00	21.21	0.00	0.00	0.00	2.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	9.60	0.00	0.00	0.00	5.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	0.00	18.02	0.00	0.00	0.00	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	24.46	0.00	0.00	0.00	6.12	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	0.00	17.52	0.00	0.00	0.00	1.31	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	13.24	0.00	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.00	14.73	0.00	0.00	0.00	3.84	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.25	14.38	0.25	0.00	0.00	1.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.00	9.05	0.00	0.00	0.00	1.39	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	11.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	0.00	18.12	0.00	0.00	0.00	2.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.00	20.13	0.00	0.00	0.00	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.36	13.49	0.36	0.00	0.00	3.55	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.00	18.24	0.00	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.42	15.38	0.00	0.00	0.00	1.25	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.00	17.48	0.00	0.00	0.58	2.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.00	15.08	0.00	0.00	0.00	1.81	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.00	17.95	0.00	0.00	0.00	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.00	18.47	0.00	0.00	0.00	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	0.57	18.78	0.57	0.00	0.00	1.14	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.83	18.52	0.14	0.00	0.00	1.66	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.78	14.51	0.52	0.26	0.26	1.04	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.43	11.58	0.00	0.00	0.00	1.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	12.70	0.00	0.00	0.00	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	1.60	12.81	0.00	0.00	0.00	1.07	0.00	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	0.30	21.25	0.30	0.00	0.30	1.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.28	15.68	0.42	0.00	0.14	0.99	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.64	11.78	0.00	0.00	0.32	1.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	0.88	20.57	0.22	0.00	0.00	2.87	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	0.76	13.65	0.38	0.00	0.38	1.52	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.57	15.34	0.00	0.28	0.28	2.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	0.74	23.60	0.00	0.00	0.49	0.98	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1.96	13.03	0.00	0.00	0.00	1.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.59	13.23	0.00	0.00	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	1.15	21.05	0.29	0.00	0.00	1.15	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	0.00	20.20	0.00	0.00	0.00	3.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	0.00	19.36	0.00	0.00	0.00	2.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	7.13	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	0.33	22.34	0.00	0.00	0.00	2.30	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	0.00	11.57	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.00	13.05	0.00	0.00	0.00	0.59	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	0.00	25.15	0.00	0.00	0.00	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.00	12.39	0.00	0.00	0.00	1.13	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	0.00	16.78	0.00	0.00	0.00	0.53	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	0.00	13.01	0.00	0.00	0.00	1.70	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.00	17.68	0.00	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.00	16.12	0.00	0.00	0.00	1.83	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	20.22	0.00	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.00	3.74	0.00	0.00	0.00	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	7.73	0.00	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1.01	14.14	0.00	0.00	0.00	2.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.00	8.85	0.00	0.00	0.00	0.42	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	10.90	0.00	0.00	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	3.81	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	4.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	7.55	0.00	0.00	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	28.55	5.71	0.00	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	29.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	23.76	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	37.65	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	58.17	12.71	7.97	11.20	3.88	6.46	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	28.74	9.41	5.75	3.14	5.23	3.66	1.57	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	94.78	2.67	30.04	24.70	10.01	4.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	108.93	5.01	23.79	25.46	6.26	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	81.95	13.50	11.41	9.13	14.83	4.94	5.51	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	98.94	9.58	17.55	23.94	11.17	4.79	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	74.11	2.04	30.60	15.64	8.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	36.75	9.19	3.68	1.84	1.84	5.51	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	74.08	2.09	24.27	15.49	9.63	2.93	1.67	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	99.25	3.95	27.43	25.10	10.46	3.72	0.93	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	61.07	5.67	19.46	11.08	6.49	1.62	3.24	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	44.78	8.20	5.47	4.84	4.63	2.10	2.31	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	33.40	11.13	11.13	11.13	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	79.42	6.95	24.32	16.88	7.94	3.97	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	59.82	9.20	9.74	7.04	7.04	1.08	1.08	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	59.84	2.72	23.80	14.28	9.52	2.04	2.95	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	62.38	4.08	12.08	9.47	7.19	0.65	1.63	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	39.91	8.38	7.11	3.10	4.74	2.19	1.46	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	59.94	5.30	16.97	12.20	10.61	2.12	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	75.64	4.80	16.21	14.41	6.00	3.00	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	51.52	11.16	6.56	4.92	4.59	1.31	2.63	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	55.62	4.39	16.42	15.12	4.39	1.79	1.79	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	37.92	9.52	5.82	5.12	6.17	2.29	1.41	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	51.34	6.33	16.17	12.66	6.33	2.81	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	69.88	5.52	17.93	16.55	9.65	1.38	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	71.66	2.25	22.49	14.14	6.43	2.57	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	50.01	10.35	7.59	5.52	3.10	3.10	2.07	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	42.98	7.59	2.53	0.00	5.06	5.06	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	36.54	7.13	4.90	3.56	3.12	2.45	1.78	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	59.27	8.04	19.48	12.28	8.47	1.69	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	60.05	8.31	11.63	10.68	8.31	0.95	2.14	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	75.55	2.15	21.03	14.59	5.58	0.86	1.72	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	18.06	0.00	18.06	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	81.97	7.00	9.33	11.66	6.66	1.67	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	29.76	4.96	5.41	6.76	5.41	0.90	1.80	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	32.93	5.16	14.28	6.35	4.76	0.00	2.38	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	49.22	2.79	24.14	7.43	1.86	0.93	3.71	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	75.67	5.68	11.35	11.35	3.41	0.76	2.27	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	50.51	1.30	21.18	10.75	3.58	1.63	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	70.16	5.23	10.02	6.54	4.79	1.74	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	40.71	4.52	4.07	4.98	5.43	3.62	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	47.62	6.17	14.99	6.17	3.53	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	61.17	5.98	15.96	12.63	4.65	0.66	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	86.81	5.46	13.39	11.41	7.44	1.98	1.49	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	81.54	3.83	13.40	10.72	3.45	0.38	1.15	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	63.51	16.33	7.86	2.72	5.14	2.72	1.51	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	24.53	9.73	7.74	3.76	4.42	2.43	0.66	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	36.59	8.13	21.68	8.81	2.03	2.03	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	25.55	0.00	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	72.55	3.05	19.51	8.54	4.27	0.61	2.44	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	75.22	3.78	17.31	16.68	2.83	1.26	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	47.21	5.45	10.29	7.26	5.75	1.82	1.51	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	63.29	3.16	12.66	9.49	7.91	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	37.41	14.74	10.20	2.27	2.27	2.27	2.27	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	15.17	0.00	0.00	5.06	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	55.90	13.29	16.90	14.29	6.96	4.10	0.75	0.12
Myoblast, donor2	11322-117D8	77.10	15.92	12.85	14.38	7.48	5.56	1.53	0.38
Myoblast, donor3	11398-118D3	66.59	19.17	12.11	12.78	7.57	4.88	1.01	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.15	17.95	0.00	0.00	0.15	0.73	0.00	0.44
Natural Killer Cells, donor1	11230-116C6	0.00	39.36	0.00	0.00	0.00	8.61	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	0.00	41.92	0.00	0.00	0.00	7.54	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	0.00	40.86	0.00	0.00	0.00	8.83	0.18	0.18
Neural stem cells, donor1	11275-116H6	38.11	13.07	1.81	2.54	7.62	1.45	1.45	0.36
Neural stem cells, donor2	11352-117H2	21.18	11.55	0.00	3.85	1.93	1.93	0.00	0.00
Neurons, donor1	11494-119E9	3.41	3.41	0.00	2.28	1.14	1.14	0.00	0.00
Neurons, donor2	11574-120E8	15.41	4.84	0.66	0.22	2.42	0.22	0.00	0.22
Neurons, donor3	11655-122E8	9.04	1.64	1.64	0.00	0.00	0.00	1.64	0.00
Neutrophils, donor1	11233-116C9	0.00	43.62	0.00	0.00	0.00	12.06	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	40.58	0.00	0.00	0.00	17.39	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	47.65	0.00	0.00	0.00	13.44	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	166.23	18.88	11.99	11.28	18.76	4.27	0.71	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	69.35	16.28	8.79	9.77	14.33	4.88	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	73.40	10.23	7.82	8.42	5.62	3.21	0.60	0.80
Olfactory epithelial cells, donor1	11933-125I7	51.76	11.56	11.84	5.64	4.27	2.48	1.93	0.28
Olfactory epithelial cells, donor2	11934-125I8	66.00	12.45	15.20	9.12	5.65	2.89	2.46	0.00
Olfactory epithelial cells, donor3	11935-125I9	53.12	12.15	11.58	9.53	5.56	2.95	1.59	0.00
Olfactory epithelial cells, donor4	11936-126A1	71.98	12.66	14.12	7.21	6.23	3.02	0.68	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	66.20	25.28	9.03	6.62	4.81	4.81	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	47.86	14.46	9.78	6.59	3.40	5.74	0.43	0.43
Osteoblast - differentiated, donor2	11353-117H3	32.01	8.00	10.29	10.29	2.29	1.14	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	34.14	8.07	11.17	3.10	2.48	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	76.61	22.28	8.60	8.99	9.19	6.06	0.98	0.20
Osteoblast, donor2	11354-117H4	89.90	11.24	8.43	5.62	13.34	3.51	0.70	0.00
Osteoblast, donor3	11426-118G4	67.89	22.93	10.13	10.84	4.98	9.06	0.00	0.71
Pancreatic stromal cells, donor1	11249-116E7	79.01	18.53	17.61	10.78	8.84	6.15	1.35	0.51
Pericytes, donor1	11491-119E6	99.14	18.69	8.79	5.23	10.46	2.34	0.89	0.22
Pericytes, donor2	11571-120E5	53.65	16.30	9.96	2.72	5.89	2.94	0.23	0.23
Pericytes, donor3	11652-122E5	79.35	21.16	12.82	12.00	6.31	6.51	0.61	0.20
Perineurial Cells, donor1	11499-119F5	132.35	18.65	10.96	9.15	10.96	7.23	0.68	0.11
Perineurial Cells, donor2	11579-120F4	104.06	25.40	12.88	15.09	11.41	7.36	0.64	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	0.00	39.20	0.00	0.00	0.00	4.46	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	0.00	34.77	0.00	0.00	0.00	4.41	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	0.00	35.59	0.00	0.00	0.00	3.75	0.00	0.39
Placental Epithelial Cells, donor1	11278-116H9	18.65	28.22	2.63	2.39	0.48	2.87	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	26.61	27.72	2.22	5.54	1.11	2.22	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	32.00	20.22	3.93	1.57	3.34	4.12	0.00	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	28.80	11.39	14.56	5.38	2.53	3.16	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	22.70	10.69	8.82	4.13	3.56	3.56	0.94	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	48.16	19.71	9.01	5.09	4.70	4.96	1.70	0.52
Preadipocyte - breast, donor2	11328-117E5	40.53	14.18	14.18	4.28	2.48	3.60	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	29.52	13.11	10.34	5.01	4.05	4.16	1.28	0.32
Preadipocyte - omental, donor2	11329-117E6	40.16	11.35	14.40	9.17	4.36	3.06	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	39.54	12.61	12.89	7.45	3.15	4.01	0.29	0.14
Preadipocyte - perirenal, donor1	11469-119C2	45.28	6.89	15.75	4.92	0.98	0.98	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	81.39	25.49	9.83	7.06	8.60	11.98	0.00	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	71.19	21.60	17.53	10.45	9.56	6.73	0.71	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	63.52	17.88	12.26	11.24	6.13	4.26	0.34	0.17
Preadipocyte - visceral, donor1	11280-116I2	67.90	19.56	11.36	8.76	9.41	7.08	1.02	0.28
Preadipocyte - visceral, donor2	11357-117H7	66.73	16.11	12.89	12.42	11.50	6.90	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	43.99	12.96	11.28	7.21	5.54	3.45	1.36	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	7.39	19.91	0.60	0.30	0.60	1.81	0.00	0.91
Prostate Epithelial Cells, donor2	11331-117E8	87.21	13.41	26.27	34.26	10.83	4.20	0.27	0.81
Prostate Epithelial Cells, donor3	11404-118D9	64.18	30.31	9.00	14.39	6.18	4.72	0.18	0.73
Prostate Stromal Cells, donor1	11254-116F3	73.92	23.58	11.62	11.85	6.95	8.88	0.46	0.34
Prostate Stromal Cells, donor2	11332-117E9	66.16	19.01	14.52	12.91	7.53	6.63	0.90	0.18
Prostate Stromal Cells, donor3	11405-118E1	70.18	15.02	11.47	10.64	5.63	4.38	0.83	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	58.76	25.91	4.38	4.38	6.93	3.65	0.36	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	49.77	16.98	4.51	3.33	5.61	3.88	0.42	0.28
Renal Epithelial Cells, donor1	11517-119H5	82.17	33.98	5.58	3.55	8.62	6.59	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	49.79	20.63	7.11	3.56	5.69	2.13	1.42	0.71
Renal Epithelial Cells, donor3	11678-122H4	53.25	24.77	7.30	3.60	9.53	3.92	0.32	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	57.19	14.30	13.62	7.49	5.45	10.21	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	65.76	9.43	14.29	10.51	6.87	6.33	1.48	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	74.60	15.98	11.32	10.88	10.88	7.55	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	58.56	9.98	12.64	7.99	7.99	12.64	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	114.45	20.25	7.92	7.26	12.77	5.72	0.88	0.22
Renal Mesangial Cells, donor2	11598-120H5	53.29	15.67	5.02	2.51	7.52	2.51	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	81.00	22.75	8.88	5.83	11.10	3.88	0.55	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	33.02	24.69	3.22	3.22	2.42	6.71	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	21.08	20.66	3.37	1.69	2.53	2.95	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	59.40	22.37	5.98	2.70	10.80	4.24	0.58	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	51.86	16.85	4.67	4.93	11.15	1.56	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	83.85	13.93	3.13	3.98	11.65	1.99	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	59.69	13.38	3.09	4.12	12.35	4.12	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	30.36	11.54	2.26	2.01	5.77	1.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	10.96	39.69	3.21	1.20	2.67	5.08	0.00	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	37.52	14.29	1.79	2.68	7.15	3.57	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	39.08	32.47	3.85	2.75	5.50	2.20	2.20	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	17.40	18.56	0.58	0.58	5.80	4.64	1.16	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	59.55	27.31	2.86	2.47	8.32	3.25	5.59	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	60.38	26.12	5.56	3.87	9.83	2.88	2.88	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	66.37	35.36	4.35	3.68	12.94	4.13	3.46	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	81.37	41.43	5.33	5.71	12.28	4.59	3.10	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	65.03	30.07	4.89	4.20	11.77	2.91	2.21	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	70.03	29.82	4.16	5.08	12.48	2.31	3.93	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	54.35	24.92	4.24	3.01	8.21	2.88	2.05	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	69.28	30.41	3.93	4.24	12.56	3.63	2.87	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	74.01	33.69	2.33	3.23	12.54	3.23	2.69	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	56.23	28.69	4.30	3.01	10.76	2.44	3.73	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	68.14	30.26	5.69	3.86	14.27	5.47	2.58	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	60.41	28.77	5.53	5.75	9.96	4.20	2.66	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	44.74	26.00	3.82	2.68	7.84	2.10	3.25	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	65.96	35.22	4.56	4.29	10.62	3.45	2.98	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	60.51	37.58	4.13	4.13	12.21	5.45	2.63	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	54.68	27.47	4.25	3.45	7.30	2.26	3.32	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	77.39	35.82	4.09	4.96	10.51	6.62	1.56	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	62.06	35.33	4.96	5.35	10.12	2.86	3.63	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	57.35	24.46	3.84	2.14	9.72	3.10	3.20	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	68.39	31.95	3.64	5.61	13.73	2.52	2.80	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	62.38	31.79	5.47	3.08	7.69	5.47	1.54	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	48.32	25.89	3.83	3.28	9.12	4.19	3.28	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	76.52	33.60	5.76	4.29	9.57	3.80	2.08	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	65.95	33.98	3.90	5.78	11.15	5.10	2.42	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	46.70	25.95	5.43	1.89	10.14	3.07	2.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	63.69	35.71	4.17	6.15	10.71	4.76	2.58	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	75.53	37.42	5.14	3.98	10.52	3.74	5.14	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	52.46	28.62	4.77	2.28	10.37	4.77	2.70	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	52.87	34.51	5.09	2.65	10.40	4.20	2.65	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	55.35	32.79	4.39	4.80	9.19	5.43	3.13	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	54.10	31.63	4.85	3.10	9.42	4.04	2.42	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	68.29	40.02	4.77	3.24	8.69	4.94	3.07	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	58.61	32.97	5.78	4.82	9.83	5.21	4.05	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	57.26	29.40	5.33	3.78	7.91	4.81	2.75	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	63.51	37.31	4.39	4.80	8.92	3.57	2.06	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	52.04	28.24	8.21	4.10	10.01	5.25	3.12	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	72.77	26.08	4.94	4.77	9.20	3.07	3.41	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	94.84	31.37	6.36	4.73	10.65	3.70	2.22	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	67.17	25.86	4.26	7.20	9.06	4.26	2.13	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	42.31	24.47	2.49	1.38	7.05	4.42	2.35	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	75.95	28.81	5.95	3.33	11.67	2.62	0.95	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	82.03	37.29	4.84	9.67	15.32	3.43	5.44	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	58.95	26.65	4.43	2.54	9.51	6.03	3.01	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	61.84	30.05	5.24	1.75	7.34	4.19	1.75	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	36.27	34.15	3.32	4.53	5.14	3.63	1.51	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	58.87	29.01	9.42	5.26	10.65	3.30	2.33	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	60.99	55.89	3.93	2.33	6.26	11.35	3.06	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	65.71	34.68	4.26	5.48	9.13	4.26	1.22	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	57.57	27.43	8.14	2.71	10.55	3.92	3.92	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	68.99	33.25	2.94	3.39	8.60	4.52	3.17	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	68.00	44.03	5.39	4.79	6.89	5.39	2.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	64.59	31.53	3.19	1.89	7.08	4.01	1.77	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	58.06	37.57	3.42	2.99	5.34	4.91	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	50.48	23.44	1.80	4.21	6.01	4.21	1.80	0.60
Schwann Cells, donor1	11498-119F4	88.39	18.43	11.28	6.77	9.40	3.76	1.13	0.94
Schwann Cells, donor2	11578-120F3	30.62	17.01	0.00	3.40	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	47.54	12.71	6.57	5.26	7.01	5.48	0.88	0.00
Sebocyte, donor1	11220-116B5	214.18	37.25	25.75	38.34	29.58	10.41	0.55	0.55
Sebocyte, donor2	11301-117B5	103.40	26.65	20.68	31.71	8.73	3.22	0.00	0.46
Sebocyte, donor3	11378-118B1	126.14	21.64	19.79	28.24	13.60	8.66	0.21	0.00
Sertoli Cells, donor1	11255-116F4	86.14	28.16	13.25	8.28	9.94	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	25.42	11.30	5.65	5.65	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	59.21	18.65	2.73	4.31	7.13	2.90	1.23	0.53
Skeletal Muscle Cells, donor2	11358-117H8	28.19	3.61	26.02	5.78	5.78	1.45	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	61.87	15.05	12.54	4.18	6.69	3.34	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	75.25	13.51	9.58	7.38	7.38	4.71	1.41	0.31
Skeletal Muscle Cells, donor5	11455-119A6	51.58	10.55	11.15	7.43	8.32	3.86	1.34	0.15
Skeletal Muscle Cells, donor6	11459-119B1	50.48	15.54	10.00	6.31	6.16	3.23	2.31	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	108.87	20.03	12.73	8.95	12.98	6.05	1.01	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	118.86	16.98	11.84	12.98	10.84	4.71	2.00	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	64.09	18.06	7.34	7.34	10.52	5.95	0.69	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	40.19	16.60	7.84	4.80	3.96	3.54	0.67	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	47.77	15.20	7.24	8.69	10.13	2.90	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	47.61	14.72	7.98	5.37	5.92	3.30	0.55	0.14
Skin - palm, donor1	10286-104F7	10.74	37.61	0.00	0.00	0.00	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	81.30	11.82	17.30	19.89	11.53	7.21	0.58	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	319.80	22.90	3.27	15.54	34.35	13.90	3.27	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	86.59	12.33	18.44	18.05	15.19	4.93	0.26	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	92.16	25.02	21.69	21.55	11.54	5.14	0.28	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	84.39	21.52	10.97	13.50	9.14	7.17	0.56	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	345.29	60.26	14.17	41.44	46.94	24.53	5.71	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	82.07	32.60	10.42	17.84	7.57	6.97	0.45	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	63.57	14.50	20.06	11.73	2.78	4.32	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	60.25	10.23	10.00	5.78	6.45	6.00	2.67	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	91.11	17.05	12.34	14.11	11.76	4.11	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	99.89	36.68	10.83	8.62	10.39	7.51	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	79.54	16.93	14.18	20.08	7.09	9.45	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	75.71	19.31	10.04	10.04	10.82	5.41	2.32	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	57.04	20.02	8.01	2.00	8.01	6.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	74.26	15.84	18.36	10.25	6.39	4.92	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	68.27	15.74	11.75	10.64	6.87	4.65	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	33.16	8.58	15.11	6.27	3.84	2.69	0.64	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	61.21	15.95	8.47	4.23	2.60	5.54	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	59.07	13.29	4.73	5.91	5.32	2.07	0.59	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	63.35	10.11	9.54	10.53	4.13	3.56	0.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	91.42	20.01	7.97	9.60	9.44	6.18	0.65	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	70.63	13.70	4.87	5.78	3.96	5.48	0.91	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	57.33	16.67	4.29	5.56	6.06	7.07	0.51	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	79.57	30.60	6.12	6.12	12.24	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	39.58	11.92	15.74	7.15	5.72	4.77	0.95	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	61.94	11.65	6.34	5.31	5.46	4.13	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	66.94	10.55	10.55	7.96	5.60	4.30	1.08	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	67.80	14.27	8.92	8.61	4.62	4.83	0.63	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	73.01	19.18	17.94	13.92	6.19	8.82	0.46	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	77.61	23.71	16.17	31.26	18.32	5.39	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	51.70	9.56	14.35	6.28	4.18	3.59	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	98.32	26.29	6.83	8.88	9.90	7.17	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	94.71	16.88	6.99	6.05	8.64	4.48	1.10	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	105.47	12.28	23.15	19.93	19.93	3.93	0.70	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	101.72	16.61	20.93	20.71	9.33	5.92	0.91	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	50.12	12.68	12.68	6.04	7.85	3.62	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	78.15	24.90	9.01	14.84	9.27	8.74	2.12	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	60.59	15.85	7.72	6.66	4.79	4.79	0.80	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	90.91	19.41	18.03	21.41	11.02	4.76	0.75	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	56.57	13.44	5.33	7.86	2.28	6.85	1.52	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	72.07	20.05	12.82	10.55	7.99	5.58	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	36.76	15.00	9.75	3.75	3.75	3.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	299.79	136.97	18.09	18.09	36.18	9.05	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	76.27	16.28	8.37	6.51	9.77	3.26	2.33	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	86.33	16.16	21.71	19.69	11.11	6.06	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	62.37	10.66	27.27	21.00	4.07	1.88	0.00	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	90.86	15.04	10.62	13.27	11.21	4.42	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	47.07	18.41	5.17	5.33	4.67	7.58	0.17	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	58.86	13.55	4.20	8.88	9.34	3.27	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	85.20	19.57	27.34	22.45	9.21	5.61	0.72	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	61.95	17.08	17.08	11.98	3.57	7.14	1.02	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	42.31	12.41	10.15	5.83	5.26	4.70	0.94	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	87.48	19.14	8.80	9.08	8.11	6.43	0.98	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	88.82	16.76	7.79	7.29	5.70	6.03	0.34	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	57.14	15.24	7.14	2.38	9.52	4.29	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	102.02	18.59	26.18	20.06	7.83	3.67	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	70.70	12.15	12.15	10.38	5.08	5.52	0.22	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	42.13	20.48	5.56	5.85	6.14	4.39	0.29	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	63.94	10.30	4.86	4.28	2.92	3.11	1.94	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	46.28	7.14	10.58	7.14	4.76	3.70	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	63.23	8.18	13.76	11.16	7.07	3.35	2.23	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	78.69	13.65	19.04	12.22	6.47	2.52	2.16	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	55.36	7.10	13.06	11.64	4.83	1.70	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	38.60	9.45	4.73	3.15	4.73	3.94	1.58	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	60.44	7.87	7.87	6.86	3.81	1.52	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	81.46	6.39	6.79	4.39	10.38	1.60	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	53.50	5.02	11.70	5.02	7.11	0.84	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	34.84	11.00	7.79	1.83	2.75	1.83	0.92	0.00
Synoviocyte, donor1	11291-117A4	31.81	16.33	7.57	3.70	3.70	6.73	0.50	0.00
Synoviocyte, donor2	11368-117I9	63.36	16.26	7.54	7.04	3.69	5.03	0.17	0.00
Synoviocyte, donor3	11440-118H9	42.00	10.72	5.81	5.36	3.13	1.79	0.89	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	139.72	40.02	8.22	10.72	14.65	5.36	1.07	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	87.21	23.78	7.93	19.82	9.91	3.96	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	84.98	21.53	8.80	7.18	9.49	6.71	1.39	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	70.54	26.09	10.75	7.60	8.39	7.03	0.57	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	87.36	15.08	15.46	15.46	10.44	3.87	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	63.57	21.19	14.32	8.02	6.30	4.01	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	11.07	41.21	2.71	0.74	1.35	3.20	0.25	0.62
Urethra, donor2	10319-105A4	12.59	23.38	0.00	0.00	5.40	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	173.21	23.38	24.71	28.69	15.94	6.64	0.27	0.80
Urothelial Cells, donor2	11600-120H7	93.73	19.23	18.43	18.83	10.82	7.21	0.80	0.40
Urothelial Cells, donor3	11681-122H7	109.79	18.57	18.57	16.50	11.46	3.21	0.00	0.46
Urothelial cells, donor0	11216-116B1	179.88	30.76	27.19	21.62	13.37	7.36	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	0.00	34.70	0.00	0.00	0.00	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	0.00	31.45	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	0.00	27.38	0.00	0.00	0.00	4.11	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	0.00	34.78	0.00	0.00	0.00	0.34	0.34	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	0.00	30.21	0.00	0.00	0.00	2.32	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	0.00	31.24	0.00	0.00	0.00	4.16	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	0.00	31.20	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	0.00	27.39	0.00	0.00	0.00	1.83	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	91.04	7.53	7.28	13.57	10.49	0.86	1.97	0.62
Wilms' tumor cell line:HFWT	10597-108E3	98.56	19.36	6.16	15.84	5.28	3.52	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	25.42	27.37	3.35	2.79	6.14	4.75	0.28	0.00
achilles tendon, donor2	10292-104G4	20.67	18.60	0.00	0.00	2.07	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	1.53	26.26	0.51	0.25	0.76	1.78	0.00	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.23	24.15	0.00	0.00	0.23	1.86	0.00	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	36.92	0.00	0.00	0.00	0.95	0.00	1.31
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.00	9.80	0.00	0.00	0.00	1.36	0.00	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.28	15.74	0.00	0.00	0.00	0.56	0.00	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.21	16.92	0.00	0.00	0.21	1.27	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	28.58	27.22	10.34	2.45	5.72	1.63	0.54	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.00	14.54	0.00	0.00	0.00	1.76	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	2.45	15.11	0.00	0.00	0.41	1.23	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.00	22.13	0.00	0.00	0.00	1.55	0.00	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	9.75	0.00	0.00	0.00	0.18	0.00	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	11.70	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	18.36	0.00	0.00	0.00	1.16	0.00	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.00	30.55	0.00	0.00	0.00	1.29	0.00	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	0.00	23.09	0.00	0.00	0.00	0.88	0.00	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	0.00	20.45	0.00	0.00	0.00	0.93	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	16.45	0.00	0.00	0.00	1.23	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.61	23.33	0.92	0.31	0.31	0.61	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.43	46.51	0.85	0.00	0.00	2.99	0.00	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1.21	56.11	1.21	0.00	0.30	3.64	0.00	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.72	55.84	1.20	0.24	0.48	5.05	0.24	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	2.23	17.37	1.56	0.00	1.11	2.45	0.22	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	3.34	15.68	0.33	0.00	1.00	1.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	18.58	33.45	1.86	0.00	7.43	1.86	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	31.26	14.69	2.26	0.75	5.65	1.51	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	13.08	13.08	1.31	0.44	6.54	1.74	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	9.37	20.62	0.00	0.00	0.00	15.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	0.00	27.08	0.00	0.00	0.00	6.12	0.24	0.94
adipose tissue, adult, pool1	10010-101C1	32.73	24.51	3.26	2.33	3.41	3.88	0.31	0.00
adipose, donor1	10184-103D4	43.98	17.01	0.59	1.17	4.10	0.00	0.00	1.76
adipose, donor2	10185-103D5	92.86	8.52	2.84	6.49	15.82	0.41	0.41	0.00
adipose, donor3	10186-103D6	73.52	8.71	7.35	4.63	14.16	0.27	0.54	0.54
adipose, donor4	10187-103D7	57.21	20.80	3.47	6.07	5.20	0.00	4.33	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	104.32	16.57	19.89	22.73	29.35	1.42	2.21	0.79
adrenal gland, adult, pool1	10081-102A9	7.28	10.91	0.00	3.64	0.00	3.64	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.53	19.74	0.00	0.00	0.00	0.67	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	80.04	12.51	6.79	7.50	8.93	8.22	7.50	0.00
amniotic membrane cells, donor1	12235-129G3	10.43	19.94	2.55	0.70	0.23	4.87	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	6.09	19.95	1.69	0.00	0.34	5.07	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	14.14	19.74	1.47	0.00	0.29	2.95	0.00	0.29
amygdala - adult, donor10196	10167-103B5	29.64	4.74	1.19	0.00	2.37	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	13.38	14.19	2.64	1.42	2.03	1.01	0.41	0.00
amygdala, newborn, donor10223	10360-105E9	11.30	5.16	1.94	1.61	3.23	0.65	1.29	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	85.82	10.19	1.78	2.55	7.77	3.31	0.00	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.44	19.41	0.00	0.00	0.00	1.54	0.00	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	71.15	6.68	1.34	1.67	12.36	0.33	0.33	0.00
aorta, adult, pool1	10052-101G7	18.63	20.99	3.73	1.37	3.92	2.94	0.59	0.39
appendix, adult	10189-103D9	10.48	19.02	2.33	0.39	1.55	2.72	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.00	9.29	0.00	0.00	0.00	0.69	0.00	0.00
artery, adult	10190-103E1	2.72	23.10	0.00	0.00	2.72	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	9.13	23.18	1.16	0.43	2.03	0.58	0.00	0.43
b cell line:RPMI1788	10427-106D4	7.14	16.06	3.12	0.59	0.74	0.45	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	51.05	10.27	16.65	9.43	3.61	3.05	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	0.89	37.51	0.00	0.00	0.10	7.44	0.00	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	18.24	60.93	1.17	0.84	1.84	9.71	0.00	1.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.00	25.72	0.00	0.00	0.00	1.68	0.56	0.00
bladder, adult, pool1	10011-101C2	25.10	30.96	3.15	2.17	2.50	4.56	0.00	0.33
blood, adult, pool1	10053-101G8	0.00	8.86	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	73.65	16.27	4.28	5.99	4.28	6.85	0.00	0.00
bone marrow, adult	10192-103E3	50.61	22.94	9.45	8.77	12.15	3.37	0.00	0.67
brain, adult, donor1	10084-102B3	6.15	8.20	0.00	0.00	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	7.24	6.46	0.22	0.45	1.00	1.34	0.00	0.22
brain, fetal, pool1	10085-102B4	8.01	2.67	2.67	2.67	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	0.00	37.00	0.00	0.00	0.00	6.61	0.00	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.12	52.92	0.00	0.00	0.00	8.74	0.00	0.12
breast, adult, donor1	10080-102A8	28.41	10.10	5.68	2.53	1.89	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	22.99	25.28	5.46	4.07	2.92	3.05	0.64	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	19.17	33.09	0.93	3.40	2.16	4.64	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	56.40	19.57	3.91	7.83	28.55	4.37	0.92	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	114.26	40.19	15.74	18.16	9.44	13.07	2.42	1.21
carcinoid cell line:NCI-H1770	10703-109H1	29.15	14.58	2.35	0.94	2.35	0.47	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	2.30	27.45	0.66	0.66	0.44	6.89	0.11	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	12.36	4.44	0.32	0.00	1.58	0.95	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	7.72	8.52	1.33	0.27	3.19	1.33	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	19.57	5.76	0.00	0.00	2.30	1.15	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	16.90	11.04	1.17	1.00	3.35	1.51	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	1.53	2.29	0.00	0.00	0.76	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	8.06	4.76	2.93	0.37	3.30	0.37	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	17.48	11.65	5.83	0.00	8.74	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	18.58	12.17	1.28	0.85	3.84	0.64	0.64	0.00
cerebellum, adult, pool1	10083-102B2	5.52	2.41	0.69	0.00	2.07	0.69	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	6.64	5.81	2.49	0.83	2.49	0.00	3.32	0.00
cerebral meninges, adult	10188-103D8	8.32	4.29	1.01	0.00	1.01	1.01	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	3.65	7.31	0.00	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	8.63	31.20	0.43	0.72	1.01	4.74	0.29	0.43
cervical cancer cell line:ME-180	10553-107I4	12.76	26.85	0.50	0.17	0.83	4.47	0.00	0.50
cervix, adult, pool1	10013-101C4	27.40	31.29	3.04	1.89	3.57	4.09	0.10	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	34.42	25.92	3.48	2.65	4.60	8.50	1.25	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	61.39	19.59	6.53	3.92	6.53	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	4.97	37.41	0.37	0.00	0.99	4.23	0.12	0.25
choriocarcinoma cell line:SCH	10785-110H2	17.00	17.74	0.74	0.49	1.97	0.86	0.49	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	8.78	22.77	0.24	0.00	1.90	2.37	0.00	0.47
chorionic membrane cells, donor1	12238-129G6	15.39	39.60	0.85	1.42	0.57	12.25	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	50.11	21.58	5.37	5.07	2.88	4.97	0.20	0.00
chorionic membrane cells, donor3	12240-129G8	11.54	39.56	2.20	0.55	0.55	7.69	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	21.21	0.00	0.00	0.00	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	4.23	33.81	0.19	0.19	1.34	3.84	0.19	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	7.18	23.23	1.90	0.00	1.69	3.59	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	4.88	23.11	1.03	0.26	0.77	2.05	0.00	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	6.53	23.46	0.24	0.00	1.94	2.42	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	9.57	24.43	0.61	0.81	1.83	2.44	0.41	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	3.53	27.38	0.00	0.29	0.59	2.06	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	8.08	36.49	0.26	0.00	1.04	2.87	0.00	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	47.77	18.74	2.97	1.14	14.86	2.74	0.69	0.23
clear cell carcinoma cell line:TEN	10636-108I6	1.21	35.40	0.00	0.00	0.17	10.06	0.17	0.52
colon carcinoma cell line:CACO-2	10513-107D9	9.70	16.66	0.55	1.28	1.65	1.65	0.00	0.55
colon carcinoma cell line:COLO-320	10420-106C6	3.42	26.23	0.00	0.00	3.42	2.66	0.00	1.52
colon, adult, donor1	10082-102B1	2.38	14.28	1.19	0.00	1.19	5.95	2.38	0.00
colon, adult, pool1	10014-101C5	12.22	36.66	2.82	0.59	0.47	10.34	0.12	0.35
colon, fetal, donor1	10070-101I7	6.80	19.78	2.47	0.62	0.00	3.71	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	0.00	59.59	0.00	0.00	0.00	22.92	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	5.10	20.40	3.82	1.27	1.70	3.40	2.12	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	5.74	13.73	2.87	0.75	2.11	0.91	0.91	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	6.06	13.82	2.82	0.99	2.54	2.40	0.99	0.14
corpus callosum, adult, pool1	10042-101F6	9.29	13.82	0.55	0.11	1.00	2.32	0.22	0.77
cruciate ligament, donor2	10295-104G7	21.07	25.12	4.05	1.62	2.43	2.43	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	21.67	12.04	5.62	2.41	0.00	4.82	0.80	0.00
diencephalon, adult	10193-103E4	3.12	2.16	0.24	0.00	0.72	0.96	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	17.45	0.00	0.00	0.00	1.38	0.00	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	2.05	48.21	0.00	0.26	1.03	5.90	0.00	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	103.75	16.37	20.70	32.26	13.24	10.35	0.48	0.72
ductus deferens, adult	10196-103E7	9.47	38.87	5.98	1.00	0.50	8.97	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	10.08	15.84	5.76	1.44	0.00	7.20	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	19.13	26.48	0.74	0.00	2.94	4.41	0.00	0.00
dura mater, adult, donor1	10041-101F5	82.84	54.01	11.07	11.23	7.43	8.34	0.66	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	0.67	15.77	0.00	0.00	0.44	0.67	0.00	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	1.29	16.05	0.14	0.00	0.72	2.01	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	128.26	15.42	5.55	10.48	12.33	1.85	1.23	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	93.54	10.90	2.72	6.96	13.92	2.72	1.51	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	123.19	20.07	3.40	10.81	10.19	2.47	1.85	0.31
embryonic pancreas cell line:2C6	10603-108E9	118.21	13.13	0.00	0.00	7.88	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	108.94	40.56	2.35	15.08	13.41	12.07	2.01	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	127.77	16.85	10.15	15.22	19.75	3.44	2.54	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	3.70	26.05	0.00	0.32	1.93	4.66	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	52.36	31.68	4.34	2.67	4.45	5.45	0.56	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	0.88	23.32	0.00	0.00	0.22	4.73	0.22	0.11
epididymis, adult	10197-103E8	19.05	25.12	3.14	1.26	1.67	3.35	0.42	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	161.27	11.18	13.48	16.32	16.85	3.90	1.77	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	48.37	5.51	28.71	16.91	4.72	4.33	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	13.37	34.34	0.52	1.18	1.97	5.24	0.79	1.31
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	12.01	35.92	0.98	0.79	2.85	5.41	0.59	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	17.14	34.39	0.78	0.78	3.70	5.15	1.01	1.34
esophagus, adult, pool1	10015-101C6	15.29	30.26	1.81	0.32	1.59	3.08	0.00	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	278.78	28.18	19.91	44.21	32.06	19.04	0.50	0.50
eye - muscle inferior rectus, donor1	10272-104E2	19.32	33.80	4.83	0.00	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	6.31	12.63	2.10	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	4.46	7.44	0.00	0.00	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	10.32	9.17	4.59	1.15	1.15	0.00	2.29	2.29
eye - vitreous humor, donor1	10268-104D7	5.83	7.29	0.00	0.00	1.46	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	18.05	11.44	2.03	1.27	1.27	2.03	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	33.72	15.39	2.31	3.59	5.39	3.97	2.05	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	38.70	11.87	8.07	4.51	6.89	1.19	2.14	0.00
frontal lobe, adult, pool1	10040-101F4	8.91	6.38	0.75	0.19	1.69	0.47	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	42.64	34.23	3.90	3.60	3.00	5.70	0.60	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	7.95	37.40	0.46	0.18	1.74	6.31	0.09	0.46
gall bladder, adult	10198-103E9	15.69	27.28	2.41	1.69	2.17	6.04	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	0.00	30.60	0.00	0.00	0.00	0.54	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	0.37	31.37	0.00	0.00	0.00	1.87	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	1.69	28.09	0.21	0.21	0.21	5.07	0.21	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	0.58	24.18	0.00	0.00	0.19	3.87	0.00	0.58
gastric cancer cell line:AZ521	10549-107H9	42.96	24.43	3.93	5.90	13.77	1.97	2.30	0.82
gastric cancer cell line:GSS	10560-108A2	23.80	9.15	1.83	3.66	10.98	1.83	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	31.76	22.39	7.31	2.74	1.60	2.06	0.23	1.60
giant cell carcinoma cell line:LU65	10487-107B1	0.00	29.03	0.00	0.00	0.00	4.13	0.00	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	257.39	34.15	13.02	25.05	45.77	9.66	1.96	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	89.79	26.44	5.74	12.72	7.48	6.24	0.25	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	122.55	27.55	12.46	11.72	16.57	6.54	4.12	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	158.56	24.30	8.15	16.71	15.03	3.65	5.48	0.42
glioblastoma cell line:T98G	10485-107A8	56.07	23.95	7.17	6.18	6.29	5.19	2.21	0.33
glioma cell line:GI-1	10413-106B8	51.55	21.09	28.12	5.27	4.39	2.05	1.17	0.59
globus pallidus - adult, donor10196	10175-103C4	16.04	8.02	0.00	2.19	0.00	1.46	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	16.84	21.72	3.42	0.73	0.98	2.44	0.73	1.71
globus pallidus, adult, donor10258	10367-105F7	8.22	6.85	1.37	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	10.66	11.19	5.86	3.20	6.40	2.66	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	2.45	53.84	0.00	0.00	0.00	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	21.86	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	20.91	0.00	0.00	0.00	10.45	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	23.04	9.28	2.88	0.96	3.52	1.60	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	34.43	8.26	1.38	1.84	8.72	0.00	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	37.50	2.74	0.46	2.29	7.77	0.46	0.91	0.91
hIPS +CCl2, biol_rep3	14385-156C2	57.32	2.58	0.64	1.29	4.51	0.00	1.29	0.00
hIPS, biol_rep1	14380-156B6	76.18	4.31	0.00	4.31	2.87	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	65.16	2.74	0.69	2.06	1.37	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	12.14	3.31	0.00	1.10	3.31	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	17.24	11.21	2.01	0.57	6.03	1.15	0.00	0.57
heart - mitral valve, adult	10205-103F7	21.23	19.13	3.89	2.09	1.79	3.89	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	11.77	23.01	3.14	1.05	1.83	2.35	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	52.46	19.98	11.66	6.66	2.50	4.16	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	5.51	22.04	1.22	0.20	1.22	2.65	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	4.26	22.99	2.13	0.43	0.43	0.85	0.00	0.00
heart, adult, pool1	10016-101C7	6.44	22.08	1.61	0.00	0.46	1.84	0.00	0.00
heart, fetal, pool1	10046-101G1	19.61	31.01	2.57	0.82	1.54	2.67	0.31	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	76.51	12.03	12.34	12.03	4.63	2.16	1.23	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	8.32	30.92	1.19	1.19	1.19	4.76	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	24.64	19.89	3.20	2.10	3.43	1.33	0.11	1.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	27.92	22.70	3.16	2.67	3.64	2.43	0.12	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	31.12	25.06	3.03	3.54	4.24	2.22	0.10	1.52
hepatoma cell line:Li-7	10484-107A7	15.13	38.26	0.78	0.56	1.11	6.67	0.22	1.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	1.51	18.69	0.90	0.20	0.30	1.71	0.10	0.60
hippocampus - adult, donor10196	10169-103B7	16.09	4.73	0.00	0.00	0.95	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	13.47	8.98	3.47	1.63	2.04	1.84	0.41	0.00
hippocampus, adult, donor10258	10374-105G5	7.47	2.99	0.00	0.00	1.00	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	10.22	3.52	2.82	2.47	3.88	0.35	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	55.54	18.92	5.49	2.44	13.43	0.61	4.88	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	60.48	12.96	4.52	3.14	12.17	0.39	3.73	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	55.86	12.44	3.05	3.81	12.69	0.76	2.54	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	28.19	11.84	0.56	1.13	9.02	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	30.73	7.49	2.84	1.55	7.75	0.26	0.52	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	25.05	7.59	0.76	0.00	5.69	0.38	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	31.53	8.76	0.29	1.75	8.76	0.00	0.29	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	39.85	9.69	2.37	2.59	10.34	0.43	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	30.86	9.59	2.09	1.67	10.01	0.42	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	27.94	8.29	2.37	0.71	4.74	0.71	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	28.77	8.52	3.05	3.70	10.45	0.80	0.32	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	26.26	8.08	0.67	2.02	7.41	0.67	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	61.03	12.21	5.79	7.04	13.14	0.31	3.29	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	50.11	9.83	5.40	5.90	7.86	0.00	3.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	26.18	19.20	6.98	2.62	13.96	0.00	5.24	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	64.53	16.61	3.25	3.82	9.55	0.57	0.76	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	79.37	9.59	2.18	5.67	10.90	0.44	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	61.47	12.49	4.00	4.00	8.00	0.00	1.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	77.05	9.42	3.96	5.84	12.06	0.57	0.57	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	75.94	6.37	4.55	3.18	16.82	0.00	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	81.75	9.08	2.51	1.88	15.35	0.00	1.25	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	82.96	8.17	6.21	6.53	14.37	1.31	1.31	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	81.00	6.97	4.94	6.97	18.29	1.45	0.29	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	98.64	6.28	5.98	6.88	20.33	0.90	1.20	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	61.70	13.49	6.28	7.76	12.38	0.74	4.06	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	83.30	10.56	5.14	7.13	10.56	0.00	3.42	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	67.78	17.15	7.35	6.53	13.47	0.82	3.67	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	77.46	9.51	3.52	2.11	11.27	1.06	1.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	80.14	10.77	5.07	4.75	9.50	0.00	0.32	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	68.69	10.29	4.54	4.84	10.59	0.30	0.30	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	82.74	12.41	2.59	5.17	12.93	0.00	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	87.67	7.97	5.98	6.64	15.28	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	61.31	5.39	1.54	1.28	12.57	0.51	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	61.61	9.71	4.60	5.11	11.25	1.28	1.28	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	68.91	6.06	3.79	4.54	14.39	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	70.24	4.37	7.73	6.39	14.45	1.34	1.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	70.04	13.04	3.62	5.55	12.08	0.48	3.38	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	43.67	11.14	5.79	1.78	15.15	0.89	2.67	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	88.29	7.32	5.37	7.32	15.12	0.00	2.93	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	39.12	10.70	3.67	2.44	6.42	0.31	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	32.53	16.27	3.25	0.00	3.25	3.25	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	30.78	7.94	2.32	0.33	6.29	0.00	0.00	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	39.95	7.11	0.55	1.09	9.85	0.00	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	43.43	7.24	2.17	1.45	10.49	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	29.18	1.78	1.78	1.07	9.25	0.71	0.00	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	26.25	8.35	2.39	1.19	13.13	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	54.17	10.56	2.71	2.84	12.87	0.27	0.54	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	36.64	5.12	3.77	1.89	12.12	0.54	0.54	0.27
immature langerhans cells, donor1	11904-125F5	0.00	25.67	0.00	0.00	0.00	4.84	0.00	0.24
immature langerhans cells, donor2	11905-125F6	0.00	20.60	0.00	0.00	0.00	7.13	0.00	0.79
insula, adult, pool1	10039-101F3	9.75	7.76	1.23	0.47	2.74	0.85	0.09	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	8.13	35.44	5.85	0.65	0.98	4.88	0.33	0.98
kidney, adult, pool1	10017-101C8	11.92	35.34	2.70	1.70	0.80	3.90	0.00	0.20
kidney, fetal, pool1	10045-101F9	19.45	36.92	2.26	0.85	1.70	5.45	0.14	0.64
large cell lung carcinoma cell line:IA-LM	10509-107D5	128.24	41.04	10.65	8.52	12.50	9.66	0.14	1.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	98.01	28.34	6.22	8.16	11.20	4.15	1.52	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	4.59	21.84	0.00	0.00	0.92	4.04	0.00	0.55
left atrium, adult, donor1	10079-102A7	9.81	4.90	4.36	2.72	2.72	1.63	0.00	0.00
left ventricle, adult, donor1	10078-102A6	4.05	10.11	0.51	0.51	1.01	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	88.65	9.03	8.21	10.94	8.76	4.38	2.46	0.00
leiomyoma cell line:10964C	10569-108B2	55.32	12.57	21.91	27.66	12.57	5.39	1.08	0.00
leiomyoma cell line:15242A	10570-108B3	50.54	10.33	19.02	16.85	9.78	3.80	1.09	0.00
leiomyoma cell line:15425	10571-108B4	59.49	17.97	15.30	20.88	7.77	5.10	0.49	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	6.35	6.35	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	25.09	8.36	2.09	1.05	7.32	2.09	6.27	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	65.76	15.47	6.97	5.31	5.78	5.78	0.35	0.00
liposarcoma cell line:KMLS-1	10782-110G8	78.89	24.21	7.81	7.50	10.15	8.12	0.62	0.47
liposarcoma cell line:SW 872	10726-110A6	60.68	17.30	7.68	9.75	3.78	5.12	0.61	0.24
liver, adult, pool1	10018-101C9	20.58	41.97	5.19	1.78	1.46	5.83	0.32	0.97
liver, fetal, pool1	10086-102B5	35.75	15.99	7.53	6.58	0.94	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	23.48	6.56	4.37	4.08	4.23	1.60	0.44	0.00
locus coeruleus, adult, donor10252	10165-103B3	17.72	11.44	2.95	0.74	1.66	2.77	0.37	0.00
locus coeruleus, adult, donor10258	10375-105G6	10.44	3.10	3.39	0.85	1.13	0.85	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	11.78	18.93	4.21	2.10	0.84	1.26	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	31.83	23.94	14.25	3.32	3.32	2.63	1.25	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	33.09	19.30	0.69	3.45	5.52	4.83	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	15.95	35.19	1.45	1.45	1.32	4.61	0.40	0.66
lung, adult, pool1	10019-101D1	24.10	35.32	2.01	2.01	2.01	3.54	0.35	0.35
lung, fetal, donor1	10068-101I5	19.41	39.67	2.00	0.29	2.00	5.71	0.57	0.57
lung, right lower lobe, adult, donor1	10075-102A3	6.87	18.33	3.21	1.37	0.00	1.83	0.92	0.00
lymph node, adult, donor1	10077-102A5	25.09	13.25	7.10	2.84	2.37	0.95	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	21.92	50.85	12.71	1.97	2.19	5.70	0.00	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.30	17.51	0.00	0.00	0.00	0.60	0.00	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	11.89	31.43	0.00	0.00	0.00	10.19	1.70	0.00
mature adipocyte, donor1	12231-129F8	47.95	30.19	2.22	9.32	2.66	7.99	0.00	0.44
mature adipocyte, donor2	12232-129F9	29.68	23.87	2.28	3.11	2.49	4.98	0.00	0.42
mature adipocyte, donor3	12233-129G1	55.00	23.71	2.84	4.27	4.03	5.93	0.24	0.24
mature adipocyte, donor4	12234-129G2	24.74	29.48	2.90	2.11	2.11	7.37	0.26	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	4.77	43.84	1.67	0.00	2.14	5.72	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	19.18	9.02	1.13	4.51	2.26	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	13.61	10.67	1.66	0.55	2.21	0.92	0.74	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	6.04	2.86	0.32	0.00	1.59	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	8.10	5.97	2.13	1.71	0.43	1.71	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	14.01	5.06	2.53	1.01	1.86	0.84	0.34	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	14.22	12.10	1.27	0.85	1.70	0.42	0.85	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	3.85	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	14.35	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	14.72	1.79	2.87	2.15	4.67	0.00	2.51	0.00
medulla oblongata - adult, donor10196	10174-103C3	14.28	7.79	0.65	0.65	0.65	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	12.85	16.10	1.39	0.93	2.17	1.08	0.46	0.00
medulla oblongata, adult, pool1	10038-101F2	9.88	14.61	1.80	0.41	1.47	1.71	0.08	0.08
medulla oblongata, newborn, donor10223	10361-105F1	7.64	7.64	2.78	1.04	2.78	0.69	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	13.51	19.48	0.89	0.44	1.77	0.66	0.44	0.44
medulloblastoma cell line:ONS-76	10759-110E3	79.23	22.62	5.87	11.37	12.11	2.81	1.47	0.37
melanoma cell line:COLO 679	10514-107E1	33.64	30.62	2.30	3.88	4.31	5.75	0.29	1.29
melanoma cell line:G-361	10465-106H6	31.22	29.59	1.90	0.81	3.80	2.17	0.00	0.54
meningioma cell line:HKBMM	10691-109F7	54.81	23.88	3.44	2.53	4.16	5.25	0.54	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	19.39	14.98	1.76	1.76	4.41	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	95.13	18.40	5.44	9.85	15.03	1.56	0.00	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	46.34	24.24	6.75	5.06	6.14	4.14	0.61	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	39.45	14.91	11.63	4.54	2.54	4.18	0.55	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	27.33	11.59	11.18	3.31	4.97	2.90	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	42.70	12.36	5.62	5.90	3.51	2.53	0.84	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	46.99	9.05	8.28	5.39	3.66	1.54	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	55.53	14.58	6.94	6.94	10.41	4.86	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	44.11	12.87	43.77	9.61	2.57	3.95	0.51	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	52.22	13.69	5.87	6.44	4.95	3.57	0.58	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	54.25	12.87	9.42	5.97	8.22	4.24	1.19	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	60.90	16.34	17.42	11.48	8.24	4.86	0.81	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	51.93	13.51	9.53	8.54	5.26	4.55	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	59.94	12.52	36.56	11.53	8.23	4.61	1.65	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	62.68	16.74	9.13	8.30	6.09	4.29	1.11	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	52.71	12.22	10.47	9.43	7.33	4.19	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	50.02	14.09	10.62	8.37	6.12	4.90	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	67.58	16.53	24.08	8.99	6.11	4.67	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	74.28	11.79	7.24	7.97	7.55	2.28	1.03	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	60.19	8.21	14.36	14.59	4.79	4.10	0.91	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	47.83	11.75	7.97	10.91	7.97	6.71	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	59.03	12.70	9.12	6.43	8.07	4.63	1.34	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	65.56	11.99	12.95	10.24	6.91	3.33	1.05	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	51.17	10.31	11.41	4.79	5.52	2.21	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	64.96	15.17	15.45	12.59	8.01	1.72	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	64.84	15.16	10.53	7.16	9.26	4.63	2.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	51.60	14.61	7.76	6.39	3.20	1.37	1.37	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	45.02	13.05	7.42	5.63	3.07	4.86	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	45.28	17.01	7.59	6.28	4.45	3.66	1.05	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	38.51	14.17	7.09	8.01	3.70	4.31	1.23	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	40.95	14.59	8.47	8.24	3.53	3.77	1.18	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	37.57	12.86	8.80	6.09	5.08	4.06	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	44.01	20.43	12.18	3.93	5.11	4.32	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	46.80	11.12	8.34	6.49	6.02	2.78	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	96.61	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	57.11	16.73	10.67	8.36	4.33	4.61	0.87	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	47.97	15.17	7.81	7.14	4.91	3.12	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	49.27	14.66	9.13	6.25	4.33	3.61	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	62.33	13.93	11.00	4.40	1.47	7.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	43.97	17.12	7.38	5.03	3.02	3.02	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	42.58	13.51	6.14	4.50	4.50	4.09	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	47.25	14.60	7.30	8.59	4.30	3.44	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	41.02	13.67	2.73	0.00	10.94	8.20	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	15.49	15.49	5.16	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	37.35	13.32	6.17	6.17	4.87	2.27	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	46.56	5.82	7.27	4.36	4.36	2.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	60.77	11.73	8.53	8.53	6.40	1.60	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	44.16	7.36	7.36	4.09	5.72	2.45	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	38.48	8.16	11.27	6.22	8.94	2.72	1.55	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	46.17	6.30	10.49	10.49	4.20	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	37.75	5.96	9.93	2.98	0.99	0.99	2.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	4.77	0.00	4.77	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	39.73	6.52	9.49	7.12	1.19	4.15	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	53.61	9.75	13.40	2.44	4.87	3.66	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	54.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	33.57	9.50	11.40	5.07	3.17	0.63	1.27	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	36.21	6.55	6.21	4.48	2.41	1.03	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	45.13	2.15	8.60	4.30	6.45	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	47.90	7.98	0.00	3.99	11.98	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	6.89	0.00	3.44	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	36.26	4.89	3.26	6.11	3.67	2.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	39.72	4.77	7.94	5.56	3.18	1.59	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	38.91	9.43	2.95	3.54	3.54	3.54	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	40.52	7.79	1.56	6.23	2.18	2.49	0.94	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	42.77	9.36	6.68	5.35	8.02	1.34	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	79.24	10.64	9.46	22.47	7.10	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	95.02	2.57	17.98	15.41	5.14	10.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	83.98	11.70	8.26	22.03	8.26	4.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	32.66	9.90	8.91	4.95	1.98	2.97	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	37.01	13.46	11.22	8.97	3.36	7.85	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	40.07	15.27	3.18	5.09	1.27	5.09	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	14.51	12.09	0.81	1.61	0.00	3.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	17.44	6.54	0.00	2.18	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	13.94	24.07	2.53	3.80	1.27	5.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	23.06	11.53	9.10	3.64	1.21	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	13.56	18.08	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.01	6.59	7.41	3.29	0.00	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	26.79	8.93	5.56	2.38	1.98	2.38	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	33.42	13.30	7.79	5.52	1.62	3.24	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	34.63	15.28	6.11	3.06	2.04	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	125.34	8.51	5.42	6.96	3.09	3.87	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	122.37	30.24	5.43	12.99	16.30	2.60	3.31	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	108.42	12.74	12.51	22.94	8.80	4.17	1.16	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	25.64	12.82	12.82	4.27	8.55	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	35.24	12.84	7.09	8.94	4.01	4.11	2.16	0.21
mesothelioma cell line:Mero-25	10850-111F4	56.51	9.76	5.90	8.85	3.63	1.59	0.00	0.45
mesothelioma cell line:Mero-41	10851-111F5	70.16	25.91	8.80	7.33	12.22	7.82	1.22	0.49
mesothelioma cell line:Mero-48a	10852-111F6	81.71	29.01	9.30	8.64	14.61	7.53	2.44	0.66
mesothelioma cell line:Mero-82	10853-111F7	85.67	20.50	8.41	12.61	5.78	7.62	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	44.09	11.23	4.09	7.15	4.60	4.09	1.87	0.00
mesothelioma cell line:Mero-84	10855-111F9	51.57	18.45	4.55	3.54	5.81	2.53	1.77	0.25
mesothelioma cell line:Mero-95	10856-111G1	50.31	27.74	5.80	6.00	7.66	7.25	0.62	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	44.89	23.52	6.63	5.63	4.97	10.60	1.49	0.50
mesothelioma cell line:NCI-H226	10846-111E9	34.57	13.94	7.06	7.24	4.71	5.07	1.45	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	67.99	16.57	12.30	9.74	5.64	3.42	3.07	0.51
mesothelioma cell line:NCI-H28	10845-111E8	19.85	17.05	1.02	1.27	4.83	1.27	2.80	0.51
mesothelioma cell line:No36	10857-111G2	23.81	11.42	1.30	0.98	5.55	3.91	1.96	0.65
mesothelioma cell line:ONE58	10858-111G3	50.40	15.17	5.15	5.69	6.23	8.40	1.08	0.27
migratory langerhans cells, donor1	11901-125F2	2.49	25.53	0.38	0.00	0.00	2.11	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	0.98	19.66	0.00	0.24	0.49	1.59	0.00	0.37
migratory langerhans cells, donor3	11903-125F4	1.79	12.56	0.18	0.18	0.18	1.79	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	41.14	15.34	4.24	2.61	1.31	2.29	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	28.82	4.24	2.54	2.33	3.39	1.48	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	73.25	35.48	4.38	8.52	3.23	9.68	0.69	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	2.47	10.47	0.00	0.19	0.38	0.76	0.95	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	0.00	60.80	0.00	0.00	0.00	3.51	0.00	1.66
myeloma cell line:PCM6	10474-106I6	4.74	38.94	1.38	0.00	0.59	5.34	0.20	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	82.69	14.20	5.07	6.59	10.15	2.54	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	30.60	33.93	6.08	2.55	3.33	10.40	1.57	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	50.81	32.42	5.13	7.35	6.02	5.68	0.00	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	47.07	27.21	5.52	6.69	5.22	4.56	0.44	0.07
nasal epithelial cells, donor2	12227-129F4	81.14	39.19	4.42	8.83	6.62	11.59	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	37.04	8.51	0.69	3.68	6.21	0.46	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	59.68	47.33	7.30	2.06	11.97	6.92	5.80	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	49.56	18.14	1.27	2.74	2.32	2.32	0.21	1.48
neuroblastoma cell line:NH-12	10555-107I6	128.58	13.04	3.91	8.76	7.27	0.00	0.37	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	34.63	13.52	2.85	2.85	5.93	0.95	0.00	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	40.55	15.52	3.80	3.64	3.17	2.38	0.32	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	17.91	10.26	5.23	1.81	3.62	0.20	0.00	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	33.70	16.53	1.91	1.27	3.18	0.00	0.00	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	69.47	12.51	11.71	12.24	6.12	3.73	0.80	0.00
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00	0.00	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	26.56	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	18.94	0.00	0.00	0.00	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1.35	19.62	0.00	0.17	0.17	2.37	0.00	1.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	9.61	24.82	0.80	0.00	2.40	0.80	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	66.04	14.11	5.77	7.69	6.09	4.17	1.92	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	105.63	18.39	19.44	14.71	8.41	4.20	0.79	0.26
nucleus accumbens, adult, pool1	10037-101F1	10.03	8.44	0.37	0.37	1.59	0.94	0.28	0.09
occipital cortex - adult, donor10196	10172-103C1	8.24	8.24	0.00	0.00	4.12	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	12.61	15.57	0.81	0.54	2.42	1.88	0.27	0.54
occipital cortex, newborn, donor10223	10355-105E4	10.19	4.37	2.91	1.09	2.55	1.46	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	3.67	2.36	1.05	0.26	0.79	0.26	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	1.29	2.15	0.00	0.43	3.43	0.43	0.00	0.43
occipital pole, adult, pool1	10036-101E9	6.78	7.65	0.47	0.39	1.02	0.71	0.08	0.08
olfactory region, adult	10195-103E6	6.50	6.50	0.76	0.00	0.96	1.15	0.19	0.19
optic nerve, donor1	10277-104E7	4.00	12.01	2.00	0.00	2.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	77.57	33.26	27.11	7.63	8.66	4.21	1.03	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	13.88	9.75	0.27	0.69	3.16	0.96	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	35.56	22.01	5.42	6.26	3.05	4.91	0.34	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	6.24	26.80	0.35	0.12	0.69	6.01	0.58	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	41.16	15.29	5.59	4.70	2.94	3.53	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	17.75	14.95	0.00	0.00	1.87	2.80	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	67.65	29.48	35.20	7.85	3.82	3.18	1.70	0.21
ovary, adult, pool1	10020-101D2	28.83	26.21	1.48	1.05	2.45	3.41	0.09	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	42.16	14.85	5.50	4.40	7.52	3.12	1.65	0.18
pancreas, adult, donor1	10049-101G4	2.82	25.40	0.94	0.94	0.00	4.70	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	4.19	21.80	0.28	0.00	0.56	2.52	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	29.98	24.36	3.75	2.73	3.07	6.30	1.19	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	5.80	29.31	0.33	0.00	1.32	6.46	0.00	0.50
paracentral gyrus, adult, pool1	10035-101E8	9.61	6.96	0.82	0.27	1.56	0.73	0.00	0.09
parietal cortex, adult, donor10258	10373-105G4	7.34	1.47	0.00	0.00	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	15.05	2.82	0.00	0.00	1.88	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	13.40	9.41	0.86	0.57	3.71	0.29	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	9.25	8.20	1.15	0.18	1.85	0.70	0.00	0.09
parietal lobe, fetal, donor1	10072-101I9	4.85	1.94	0.00	0.97	0.97	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	12.34	4.49	0.75	3.36	0.75	0.00	1.12	0.37
parotid gland, adult	10199-103F1	1.85	29.60	1.85	0.00	0.00	1.23	0.00	1.85
penis, adult	10200-103F2	13.43	20.41	3.22	2.15	2.15	1.61	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	8.37	15.06	5.95	0.37	1.67	0.56	1.49	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	9.18	21.13	1.89	0.44	0.87	2.62	0.44	0.15
pineal gland - adult, donor10196	10179-103C8	17.42	8.39	1.29	1.29	3.23	1.94	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	27.83	16.58	1.78	2.96	3.55	1.78	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	16.30	3.76	2.51	0.00	3.14	0.63	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	44.52	20.24	8.09	3.04	3.04	4.05	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	47.95	32.83	4.69	0.52	5.21	2.61	1.04	3.13
pituitary gland, adult, donor10258	10378-105G9	13.62	7.66	0.85	0.85	5.96	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	11.83	57.41	0.65	0.32	1.08	8.92	0.11	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	0.00	19.73	0.00	0.00	0.00	0.26	0.00	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	88.71	18.83	14.01	9.03	4.98	7.16	3.89	0.31
pons, adult, pool1	10033-101E6	6.20	9.64	1.20	0.34	1.29	1.03	0.09	0.17
postcentral gyrus, adult, pool1	10032-101E5	8.89	6.10	0.70	0.26	1.31	0.70	0.00	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	56.47	0.00	0.00	0.00	10.46	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	11.02	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	23.47	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	221.70	27.38	11.51	27.24	62.63	3.50	5.39	1.02
prostate cancer cell line:PC-3	10439-106E7	15.06	25.23	0.91	0.54	4.17	4.36	0.73	0.36
prostate, adult, pool1	10022-101D4	20.86	29.38	2.18	1.72	2.36	3.08	0.00	0.45
putamen, adult, donor10196	10176-103C5	19.12	8.50	1.89	2.36	2.12	0.24	0.24	0.24
putamen, adult, donor10252	10152-102I8	7.84	11.76	3.92	0.00	1.96	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	32.78	2.19	0.00	0.00	4.37	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	3.38	3.14	0.24	0.00	0.72	0.48	0.00	0.00
putamen, newborn, donor10223	10365-105F5	8.25	6.75	3.00	1.50	2.25	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	23.57	23.27	1.16	0.29	1.45	5.53	0.58	0.00
rectum, fetal, donor1	10067-101I4	25.04	12.52	2.78	2.78	6.95	4.17	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	41.34	25.65	4.66	1.70	7.00	4.24	2.54	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.20	22.78	0.41	0.41	4.56	3.73	0.41	0.41
retina, adult, pool1	10030-101E3	30.91	31.11	2.68	0.99	3.08	4.57	0.30	0.30
retinoblastoma cell line:Y79	10475-106I7	2.60	7.01	0.00	0.00	0.78	1.04	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	86.56	6.27	9.10	10.94	11.07	1.35	0.37	0.74
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	92.80	28.68	3.37	3.66	13.50	5.91	3.09	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	75.79	18.95	3.03	6.06	5.30	3.79	3.03	0.00
salivary acinar cells, donor1	11771-123I7	196.49	15.70	24.28	41.44	15.86	3.40	1.13	0.49
salivary acinar cells, donor2	11772-123I8	158.34	19.55	11.43	19.83	14.04	4.82	0.55	0.41
salivary acinar cells, donor3	11773-123I9	100.63	23.83	6.62	11.25	5.96	5.96	0.66	0.00
salivary gland, adult, pool1	10093-102C3	2.29	33.75	0.57	0.00	0.00	1.14	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	49.74	23.78	4.97	2.53	9.19	4.13	2.45	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	56.42	24.45	3.64	3.29	7.76	4.58	3.53	0.35
seminal vesicle, adult	10201-103F3	7.41	29.10	2.65	0.00	0.53	8.47	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	0.00	40.08	0.00	0.00	0.00	11.17	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	8.56	16.86	0.75	0.75	0.50	3.27	0.50	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	19.07	16.06	1.00	2.01	6.02	7.02	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	0.67	36.00	0.00	0.00	0.27	6.18	0.13	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	0.55	37.80	0.22	0.00	0.33	1.88	0.00	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	0.77	22.06	0.00	0.00	0.00	3.35	0.00	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	2.13	19.15	0.71	0.71	0.00	1.42	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	6.00	24.59	0.84	0.72	0.72	1.80	0.00	0.36
skeletal muscle, fetal, donor1	10066-101I3	13.07	9.05	0.00	1.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	6.79	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	25.25	17.67	1.89	3.16	1.26	3.16	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	0.00	7.34	0.00	0.00	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	9.77	11.35	0.95	0.00	1.58	1.26	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.43	38.16	0.00	0.39	2.51	0.77	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	2.14	30.82	0.00	0.00	0.66	5.93	0.00	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	5.31	13.51	0.64	0.32	2.09	0.32	0.32	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	0.00	16.34	0.00	0.00	0.00	1.53	0.00	0.22
small intestine, adult, pool1	10024-101D6	10.63	60.32	1.19	0.60	0.24	18.04	0.00	0.00
small intestine, fetal, donor1	10064-101I1	11.30	18.43	0.49	0.74	1.97	4.67	0.25	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	0.00	24.62	0.00	0.00	0.00	2.05	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	11.89	21.97	1.81	0.26	1.55	4.39	0.00	0.52
somatostatinoma cell line:QGP-1	10781-110G7	10.45	56.82	3.22	0.80	0.54	16.89	0.00	0.54
spinal cord - adult, donor10196	10181-103D1	18.58	6.42	3.21	2.52	2.52	0.92	2.52	0.00
spinal cord, adult, donor10252	10159-103A6	15.38	18.53	1.97	0.00	1.18	1.97	1.97	0.39
spinal cord, adult, donor10258	10369-105F9	7.61	3.46	0.00	0.00	0.69	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	15.86	6.71	0.61	1.22	1.83	1.22	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	11.48	14.24	2.30	1.38	1.38	0.00	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	50.18	11.20	16.43	7.02	3.29	5.38	1.05	0.45
spleen, adult, pool1	10025-101D7	24.89	28.86	3.74	1.65	2.09	6.17	0.22	0.44
spleen, fetal, pool1	10044-101F8	28.52	44.26	4.53	1.35	2.30	8.58	0.72	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	13.66	17.08	2.07	1.45	1.24	1.76	0.00	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	40.82	38.17	1.52	0.95	3.23	5.32	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	2.45	17.12	0.00	0.35	0.35	2.80	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	53.17	32.45	3.52	4.30	6.25	9.77	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	0.34	23.64	0.00	0.00	0.00	2.70	0.00	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	33.46	19.06	6.35	7.62	5.51	2.54	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	140.04	13.96	19.04	19.88	24.54	7.62	6.35	0.42
stomach, fetal, donor1	10062-101H8	12.82	40.58	5.34	2.14	3.20	9.61	1.07	0.00
submaxillary gland, adult	10202-103F4	5.70	26.77	1.14	0.00	0.57	1.14	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	10.80	13.71	1.45	0.83	1.45	2.91	0.21	0.42
substantia nigra, adult, donor10258	10371-105G2	10.35	1.03	0.00	0.00	1.55	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	14.13	4.95	1.41	2.83	0.71	1.41	2.12	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	213.90	26.37	14.44	24.07	45.39	3.90	2.06	1.15
temporal lobe, adult, pool1	10031-101E4	7.80	7.12	1.02	0.59	2.12	0.68	0.00	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	3.56	0.71	0.00	0.00	2.85	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	10.11	2.64	0.00	0.88	1.76	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	92.16	19.90	13.61	15.01	10.82	6.98	1.40	1.05
tenocyte, donor2	11765-123I1	103.01	16.02	9.16	8.01	7.25	3.82	0.76	0.38
tenocyte, donor3	11768-123I4	48.93	12.23	12.60	8.53	5.19	4.08	1.11	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	27.19	23.28	3.23	2.89	8.50	0.68	3.74	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	51.49	27.90	2.47	1.85	3.85	2.00	2.47	1.70
teratocarcinoma cell line:PA-1	10807-111A6	28.67	10.85	2.32	1.55	4.96	0.46	1.08	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	14.85	40.62	4.95	1.27	2.54	5.59	2.67	1.14
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	27.98	25.34	0.00	2.65	2.65	2.27	2.65	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	6.87	32.61	1.20	0.76	0.87	3.16	2.84	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	5.54	12.38	0.65	0.33	1.30	1.30	0.33	0.33
testis, adult, pool1	10026-101D8	21.05	19.86	1.29	0.86	2.36	2.90	0.11	0.11
testis, adult, pool2	10096-102C6	8.57	17.14	0.00	0.90	1.80	2.26	0.00	0.00
thalamus - adult, donor10196	10168-103B6	26.50	7.73	1.10	1.10	3.31	3.31	0.00	0.00
thalamus, adult, donor10252	10154-103A1	9.53	11.56	1.72	0.78	1.25	1.25	0.63	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	15.40	0.00	0.00	0.00	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	5.43	1.98	1.32	0.66	1.48	0.33	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	6.33	3.45	1.73	1.73	3.45	0.00	0.58	0.58
throat, adult	10209-103G2	7.99	22.72	1.25	0.50	0.50	1.75	0.50	0.50
throat, fetal, donor1	10061-101H7	23.77	16.15	3.96	1.83	1.22	2.44	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	8.94	15.10	0.00	1.19	2.38	1.59	0.00	0.20
thymus, adult, pool1	10027-101D9	2.49	34.00	0.20	0.00	0.20	0.89	0.10	1.19
thymus, fetal, pool1	10043-101F7	13.92	40.00	0.94	0.31	0.83	1.25	0.10	1.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	15.02	20.74	4.92	2.39	1.60	6.78	0.80	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	23.05	24.59	10.90	1.96	1.12	4.61	0.42	0.70
thyroid, adult, pool1	10028-101E1	22.77	39.94	5.51	2.61	2.15	4.95	0.09	0.65
thyroid, fetal, donor1	10060-101H6	21.09	21.09	6.86	3.43	1.05	3.16	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	46.19	0.00	3.08	0.00	6.16	3.08	0.00
tongue, adult	10203-103F5	7.91	18.14	2.56	0.93	0.93	3.26	0.00	0.23
tongue, fetal, donor1	10059-101H5	10.64	18.92	3.15	3.15	2.36	1.97	1.18	0.39
tonsil, adult, pool1	10047-101G2	8.72	50.69	0.80	0.70	1.00	4.11	0.10	0.40
trachea, adult, pool1	10029-101E2	36.97	32.56	3.60	2.37	3.19	5.81	0.33	0.41
trachea, fetal, donor1	10058-101H4	28.85	15.39	3.85	1.92	1.54	1.92	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	58.46	12.40	16.65	13.11	5.67	5.67	0.71	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	7.19	17.83	2.03	0.41	1.32	3.95	0.10	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	158.72	19.27	22.25	15.20	19.74	5.48	5.17	0.63
tridermal teratoma cell line:HGRT	10694-109G1	144.59	15.22	7.61	9.51	5.71	9.51	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	30.30	27.93	2.29	1.52	2.79	6.01	0.76	0.42
umbilical cord, fetal, donor1	10057-101H3	14.61	14.61	6.26	0.00	0.00	0.00	2.09	2.09
uterus, adult, pool1	10100-102D1	23.21	20.82	2.39	1.02	1.54	3.41	0.00	0.34
uterus, fetal, donor1	10055-101H1	39.42	11.26	4.61	2.56	4.61	3.07	0.51	0.00
vagina, adult	10204-103F6	21.97	17.45	3.23	2.58	1.29	3.88	0.00	0.00
vein, adult	10191-103E2	22.14	17.97	2.19	2.63	1.10	3.73	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.00	8.01	0.00	0.00	0.00	0.80	0.00	0.27